Skip Navigation

Immunization and Infectious Diseases Data Details

IID-1 Reduce, eliminate, or maintain elimination of cases of vaccine-preventable diseases

About the Data

Description of the data source, numerator, denominator, survey questions, and other relevant details about the national estimate.

National Data Source
National Notifiable Diseases Surveillance System (NNDSS); Centers for Disease Control and Prevention, Public Health Surveillance and Informatics Program Office (CDC/PHSIPO)
Changed Since the Healthy People 2020 Launch
No
Measure
number 
Baseline (Year)
0 (2008)
Target
0
Target-Setting Method
Total elimination
Numerator

Number of confirmed and probable U.S.-acquired cases of congenital rubella syndrome among children less than 1 year of age

Data Collection Frequency
Annual
Comparable Healthy People 2010 Objective
Retained from HP2010 objective
Methodology Notes

A case definition for confirmed and probable US acquired cases of congenital rubella syndrome (CRS) is available from CDC. Imported cases of CRS were not included. CRS counts are based on year of birth, not year of report.

References

Additional resources about the objective.

  1. Centers for Disease Control and Prevention (CDC). Case definitions for infectious conditions under public health surveillance can be found at: http://www.cdc.gov/ncphi/disss/nndss/casedef

About the Data

Description of the data source, numerator, denominator, survey questions, and other relevant details about the national estimate.

National Data Source
Active Bacterial Core Surveillance (ABCS); Centers for Disease Control and Prevention, National Center for Immunization and Respiratory Diseases (CDC/NCIRD)
Changed Since the Healthy People 2020 Launch
Yes
Measure
per 100,000 
Baseline (Year)
0.30 (2008)
Target
0.27
Target-Setting Method
10 percent improvement
Numerator
Estimated number of all reported confirmed and probable cases of Haemophilus influenzae invasive disease for children under age 5 years
Data Collection Frequency
Annual
Comparable Healthy People 2010 Objective
Adapted from HP2010 objective
Methodology Notes

Data reflect cases of Hib disease among children less than 5 years of age submitted to Active Bacterial Core surveillance.

The Active Bacterial Core surveillance (ABCs) system is an active laboratory and population-based surveillance system that provides reports of H. influenzae cases from all or parts of 10 states in the United States. ABCs is supported by the CDC as part of its Emerging Infections Program network. The population under surveillance was 36,748,349 in 2009 (representing 12.0% of the US population).

A case was defined as isolation of H. influenzae from a normally sterile body site (eg, blood or cerebrospinal fluid) in a person aged <5 years. Illness outcome was based on patient status at the time of hospital discharge. Serotyping of H. influenzae was performed by using slide agglutination or polymerase chain reaction. All isolates from ABCs sites were sent to the CDC, where serotype was confirmed by using slide agglutination, Haemophilus quad identification plates or API Neisseria-Haemophilus strips, and polymerase chain reaction. The CDC result was used as the final serotype in the ABCs data set. This measure includes confirmed cases of H. influenzae type b disease.

Caveats and Limitations
ABCs Areas California (3 county San Francisco Bay area); Colorado (5 county Denver area); Connecticut; Georgia; Maryland; Minnesota; New Mexico; New York (15 county Rochester and Albany areas); Oregon; Tennessee (20 urban counties) ABCs Population The surveillance areas represent 41,981,509 persons. Source: National Center for Health Statistics bridged-race vintage 2010 postcensal file

Revision History

Any change to the objective text, baseline, target, target-setting method or data source since the Healthy People 2020 launch.

Description of Changes Since the Healthy People 2020 Launch

The objective statement was changed from "aged 5 years or under" to "under age 5 years" to make the age group consistent with the numerator definition. The NNDSS data source was removed. NNDSS data were insufficient to assess Hib with any degree of confidence because Haemophilus influenzae serotyping information was often missing.

References

Additional resources about the objective.

  1. Centers for Disease Control and Prevention (CDC). Case definitions for infectious conditions under public health surveillance. Morbidity and Mortality Weekly Report 46 (RR-10), 1997. (Updated case definitions can be found at: http://www.cdc.gov/ncphi/disss/nndss/casedef/introduction.htm).

About the Data

Description of the data source, numerator, denominator, survey questions, and other relevant details about the national estimate.

National Data Source
National Notifiable Diseases Surveillance System (NNDSS); Centers for Disease Control and Prevention, Public Health Surveillance and Informatics Program Office (CDC/PHSIPO)
Changed Since the Healthy People 2020 Launch
No
Measure
per 100,000 
Baseline (Year)
0.1 (2007)
Target
0.0
Target-Setting Method
Total elimination
Numerator
Number of reported new symptomatic hepatitis B cases among persons aged 2 to 18 years reported in the past 12 months
Denominator
Total population aged 2-18 years in reporting states
Data Collection Frequency
Annual
Comparable Healthy People 2010 Objective
Adapted from HP2010 objective
Methodology Notes

A case definition for new symptomatic cases of hepatitis B is available from CDC.

In 1991, CDC published comprehensive strategies for eliminating transmission of hepatitis B within the United States. This strategy included universal childhood vaccination. With full implementation of this strategy, the number and rate of hepatitis B cases among persons aged 2 to 18 years should be eliminated. To obtain State-specific measures, local Viral Hepatitis Surveillance Program data are used to determine the number of symptomatic hepatitis B cases among persons aged 2 to 18 years occurring in the State in the past 12 months.

References

Additional resources about the objective.

  1. http://www.cdc.gov/mmwr/preview/mmwrhtml/rr5416a1.htm
  2. CDC. A Comprehensive Immunization Strategy to Eliminate Transmission of Hepatitis B Virus Infection in the United States. Part 1: Immunization of Infants, Children and Adolescents: recommendations of the Advisory Committee on Immunization Practices (ACIP). MMWR, December 23, 2005, Vol. 54(RR-16):1-39.
  3. Centers for Disease Control and Prevention (CDC). Case definitions for infectious conditions under public health surveillance. http://wwwn.cdc.gov/nndss/beta/bcasedefDefault.aspx

About the Data

Description of the data source, numerator, denominator, survey questions, and other relevant details about the national estimate.

National Data Source
National Notifiable Diseases Surveillance System (NNDSS); Centers for Disease Control and Prevention, Public Health Surveillance and Informatics Program Office (CDC/PHSIPO)
Changed Since the Healthy People 2020 Launch
No
Measure
number 
Baseline (Year)
115 (2008)
Target
30
Target-Setting Method
Projection/trend analysis
Numerator
Number of confirmed U.S.-acquired cases of measles
Data Collection Frequency
Annual
Comparable Healthy People 2010 Objective
Retained from HP2010 objective
Methodology Notes

A case definition for confirmed U.S. acquired cases of measles is available from CDC. Imported cases of measles were not included.

References

Additional resources about the objective.

  1. Centers for Disease Control and Prevention (CDC). Case definitions for infectious conditions under public health surveillance can be found at: http://www.cdc.gov/ncphi/disss/nndss/casedef

About the Data

Description of the data source, numerator, denominator, survey questions, and other relevant details about the national estimate.

National Data Source
National Notifiable Diseases Surveillance System (NNDSS); Centers for Disease Control and Prevention, Public Health Surveillance and Informatics Program Office (CDC/PHSIPO)
Changed Since the Healthy People 2020 Launch
No
Measure
number 
Baseline (Year)
421 (2008)
Target
500
Target-Setting Method
Projection/trend analysis
Numerator
Number of confirmed and probably US acquired cases of mumps
Data Collection Frequency
Annual
Comparable Healthy People 2010 Objective
Retained from HP2010 objective
Methodology Notes

A case definition for confirmed and probable US acquired cases of mumps is available from CDC.

References

Additional resources about the objective.

  1. Centers for Disease Control and Prevention (CDC). Case definitions for infectious conditions under public health surveillance can be found at: http://www.cdc.gov/ncphi/disss/nndss/casedef

About the Data

Description of the data source, numerator, denominator, survey questions, and other relevant details about the national estimate.

National Data Source
National Notifiable Diseases Surveillance System (NNDSS); Centers for Disease Control and Prevention, Public Health Surveillance and Informatics Program Office (CDC/PHSIPO)
Changed Since the Healthy People 2020 Launch
No
Measure
number 
Baseline (Year)
2,777 (2004-2008)
Target
2,500
Target-Setting Method
10 percent improvement
Numerator
Number of confirmed and probable cases of pertussis (including cases identified in outbreak settings) among children under age 1 year
Data Collection Frequency
Annual
Comparable Healthy People 2010 Objective
Adapted from HP2010 objective
Methodology Notes

A case definition for confirmed and probable cases of pertussis (including cases identified in outbreak settings) is available from CDC. Estimates are a five-year moving average of confirmed and probable cases of pertussis reported to NNDSS.

References

Additional resources about the objective.

  1. Centers for Disease Control and Prevention (CDC). Case definitions for infectious conditions under public health surveillance. Morbidity and Mortality Weekly Report 46 (RR-10), 1997. (Updated case definitions can be found at: http://www.cdc.gov/ncphi/disss/nndss/casedef/introduction.htm).

About the Data

Description of the data source, numerator, denominator, survey questions, and other relevant details about the national estimate.

National Data Source
National Notifiable Diseases Surveillance System (NNDSS); Centers for Disease Control and Prevention, Public Health Surveillance and Informatics Program Office (CDC/PHSIPO)
Changed Since the Healthy People 2020 Launch
No
Measure
number 
Baseline (Year)
3,995 (2000-2004)
Target
2,000
Target-Setting Method
Projection/trend analysis
Numerator
Number of confirmed and probable cases of pertussis (including cases identified in outbreak settings) among adolescents aged 11 to 18 years
Data Collection Frequency
Annual
Comparable Healthy People 2010 Objective
Not applicable
Methodology Notes

A case definition for confirmed and probable cases of pertussis (including cases identified in outbreak settings) is available from CDC. Estimates are a five-year moving average of confirmed and probable cases of pertussis reported to NNDSS.

References

Additional resources about the objective.

  1. Centers for Disease Control and Prevention (CDC). Case definitions for infectious conditions under public health surveillance. Morbidity and Mortality Weekly Report 46 (RR-10), 1997. (Updated case definitions can be found at: http://www.cdc.gov/ncphi/disss/nndss/casedef/introduction.htm).

About the Data

Description of the data source, numerator, denominator, survey questions, and other relevant details about the national estimate.

National Data Source
National Notifiable Diseases Surveillance System (NNDSS); Centers for Disease Control and Prevention, Public Health Surveillance and Informatics Program Office (CDC/PHSIPO)
Changed Since the Healthy People 2020 Launch
No
Measure
number 
Baseline (Year)
0 (2008)
Target
0
Target-Setting Method
Total elimination
Numerator
Number of US acquired cases of acute paralytic poliomyelitis
Data Collection Frequency
Annual
Comparable Healthy People 2010 Objective
Retained from HP2010 objective
Methodology Notes

A case definition for US acquired cases of acute paralytic poliomyelitis is available from CDC.

References

Additional resources about the objective.

  1. Centers for Disease Control and Prevention (CDC). Case definitions for infectious conditions under public health surveillance can be found at: http://www.cdc.gov/ncphi/disss/nndss/casedef .

About the Data

Description of the data source, numerator, denominator, survey questions, and other relevant details about the national estimate.

National Data Source
National Notifiable Diseases Surveillance System (NNDSS); Centers for Disease Control and Prevention, Public Health Surveillance and Informatics Program Office (CDC/PHSIPO)
Changed Since the Healthy People 2020 Launch
No
Measure
number 
Baseline (Year)
10 (2008)
Target
10
Target-Setting Method
Projection/trend analysis
Numerator
Number of confirmed US acquired cases of rubella
Data Collection Frequency
Annual
Comparable Healthy People 2010 Objective
Retained from HP2010 objective
Methodology Notes

A case definition for confirmed and probable US acquired cases of rubella is available from CDC. Imported cases of rubella were not included.

References

Additional resources about the objective.

  1. Centers for Disease Control and Prevention (CDC). Case definitions for infectious conditions under public health surveillance can be found at: http://www.cdc.gov/ncphi/disss/nndss/casedef

About the Data

Description of the data source, numerator, denominator, survey questions, and other relevant details about the national estimate.

National Data Source
National Health Interview Survey (NHIS); Centers for Disease Control and Prevention, National Center for Health Statistics (CDC/NCHS)
Changed Since the Healthy People 2020 Launch
No
Measure
number 
Baseline (Year)
586,000 (2008)
Target
100,000
Target-Setting Method
Projection/trend analysis
Numerator
Number of persons 17 years of age or younger who are reported to have had chicken pox (varicella) in the past year
Denominator
Number of persons 17 years of age or younger
Questions Used to Obtain the National Baseline Data

From the 2011 National Health Interview Survey:

[NUMERATOR:]

For persons age 17 years or under:

Has [PERSON] EVER had chickenpox?

  1. Yes
  2. No
  3. Refused
  4. Don't know

Has [PERSON] had chickenpox DURING THE PAST 12 MONTHS?

  1. Yes
  2. No
  3. Refused
  4. Don't know
Data Collection Frequency
Annual
Comparable Healthy People 2010 Objective
Retained from HP2010 objective
Methodology Notes

Persons are classified as having had chickenpox (varicella) in the past year if they responded “yes” to both questions on chickenpox listed under Numerator.

About the Data

Description of the data source, numerator, denominator, survey questions, and other relevant details about the national estimate.

National Data Source
Active Bacterial Core Surveillance (ABCS); Centers for Disease Control and Prevention, National Center for Immunization and Respiratory Diseases (CDC/NCIRD)
National Vital Statistics System-Natality (NVSS-N); Centers for Disease Control and Prevention, National Center for Health Statistics (CDC/NCHS)
Changed Since the Healthy People 2020 Launch
No
Measure
per 1,000 
Baseline (Year)
0.30 (2008)
Target
0.25
Target-Setting Method
10 percent improvement
Numerator
Number of newborns aged 0 to 6 days with a newly reported laboratory-confirmed case of early-onset group B streptococcal disease
Denominator
Number of live births
Data Collection Frequency
Annual
Comparable Healthy People 2010 Objective
Retained from HP2010 objective
Methodology Notes

A laboratory-confirmed case of group B Streptococcus is defined as either the isolation of group B Streptococcus from cerebrospinal fluid or a positive culture of group B Streptococcus from a different normally sterile site (blood, pleural fluid, etc.) in a newborn aged 0 to 6 days in the surveillance area. Rates were calculated using live birth estimates for 2009. Missing race data was multiply imputed and surveillance rates were standardized to the racial distribution of the live birth estimates using vital statistics data from NCHS.

Caveats and Limitations
ABCs Areas California (3 county San Francisco Bay area); Colorado (children < 1 year in 5 county Denver area); Connecticut (children < 1 year); Georgia (20 county); Maryland; Minnesota; New Mexico; New York (15 county Rochester and Albany areas); Oregon (3 county Portland area); Tennessee (20 counties) ABCs Population The surveillance areas represent 29,278,034 persons and 458,003 live births. Source: National Center for Health Statistics bridged-race vintage 2010 postcensal file and 2009 state vital records

References

Additional resources about the objective.

  1. CDC. Laboratory-based surveillance for meningococcal disease in selected areas, United States, 1989-91. Morbidity and Mortality Weekly Report 42 (SS-2).

About the Data

Description of the data source, numerator, denominator, survey questions, and other relevant details about the national estimate.

National Data Source
National Notifiable Diseases Surveillance System (NNDSS); Centers for Disease Control and Prevention, Public Health Surveillance and Informatics Program Office (CDC/PHSIPO)
Changed Since the Healthy People 2020 Launch
Yes
Measure
number 
Baseline (Year)
1,215 (2004-2008)
Target
1094
Target-Setting Method
10 percent improvement
Numerator
Number of new laboratory-confirmed meningococcal disease cases reported in past 12 months
Denominator
U.S. population
Data Collection Frequency
Annual
Comparable Healthy People 2010 Objective
Adapted from HP2010 objective
Methodology Notes

A case definition for laboratory-confirmed cases of meningococcal disease is available from CDC. Estimates are a five-year moving average of confirmed and probable cases of meningococcal disease reported to NNDSS.

Caveats and Limitations
Race/Ethnicity: Only those cases with known Race and Ethnicity are included.

Revision History

Any change to the objective text, baseline, target, target-setting method or data source since the Healthy People 2020 launch.

Description of Changes Since the Healthy People 2020 Launch

The baseline was revised from 0.3 cases per 100,000 (2004-2006) to 1,215.0 cases (2004-2008) because reports of meningococcal disease occur relatively infrequently. The target was revised from 0.3 cases per 100,000 to 1,094 cases to account for the change in unit.

References

Additional resources about the objective.

  1. Centers for Disease Control and Prevention (CDC). Case definitions for infectious conditions under public health surveillance. Morbidity and Mortality Weekly Report 46 (RR-10), 1997. (Updated case definitions can be found at: http://www.cdc.gov/ncphi/disss/nndss/casedef/introduction.htm).
  2. Klein, R.J.; Proctor, S.E.; Boudreault, M.A.; Turczyn, K.M. Healthy People 2010 Criteria for Data Suppression. Statistical Notes No. 24. Hyattsville, MD: National Center for Health Statistics. 2002.
IID-4 Reduce invasive pneumococcal infections

About the Data

Description of the data source, numerator, denominator, survey questions, and other relevant details about the national estimate.

National Data Source
Active Bacterial Core Surveillance (ABCS); Centers for Disease Control and Prevention, National Center for Immunization and Respiratory Diseases (CDC/NCIRD)
Changed Since the Healthy People 2020 Launch
No
Measure
per 100,000 
Baseline (Year)
21.1 (2008)
Target
12.0
Target-Setting Method
Projection/trend analysis
Numerator
Number of children under age 5 years with a laboratory-confirmed invasive pneumococcal infection in the past 12 months
Denominator
Number of children under age 5 years
Data Collection Frequency
Annual
Comparable Healthy People 2010 Objective
Retained from HP2010 objective
Methodology Notes

An invasive pneumococcal infection is defined as a laboratory-confirmed isolation of Streptococcus pneumoniae from a normally sterile site (blood, cerebral spinal fluid, etc.). Missing race data was multiply imputed and surveillance rates were standardized to the racial distribution of the US population using the NCHS bridged-race vintage 2010 postcensal file.

Caveats and Limitations
ABCs Areas California (San Francisco County and children < 5 years in Alameda and Contra Costa counties); Colorado (5 county Denver area); Connecticut; Georgia (20 county Atlanta area); Maryland (6 county Baltimore area); Minnesota; New Mexico; New York (15 county Rochester and Albany areas and children <5 years in Erie county); Oregon (3 county Portland area); Tennessee (20 counties) ABCs Population The surveillance areas represent 29,757,552 persons. Source: National Center for Health Statistics bridged-race vintage 2010 postcensal file

References

Additional resources about the objective.

  1. Centers for Disease Control and Prevention (CDC). Active Bacterial Core surveillance (ABCs), http://www.cdc.gov/abcs.

About the Data

Description of the data source, numerator, denominator, survey questions, and other relevant details about the national estimate.

National Data Source
Active Bacterial Core Surveillance (ABCS); Centers for Disease Control and Prevention, National Center for Immunization and Respiratory Diseases (CDC/NCIRD)
Changed Since the Healthy People 2020 Launch
No
Measure
per 100,000 
Baseline (Year)
40.7 (2008)
Target
31.0
Target-Setting Method
Projection/trend analysis
Numerator
Number of persons aged 65 years and older with a laboratory-confirmed invasive pneumococcal infection in the past 12 months
Denominator
Number of persons aged 65 years and older
Data Collection Frequency
Annual
Comparable Healthy People 2010 Objective
Retained from HP2010 objective
Methodology Notes

An invasive pneumococcal infection is defined as a laboratory-confirmed isolation of Streptococcus pneumoniae from a normally sterile site (blood, cerebral spinal fluid, etc.). Missing race data was multiply imputed and surveillance rates were standardized to the racial distribution of the US population using the NCHS bridged-race vintage 2010 postcensal file.

Caveats and Limitations
ABCs Areas California (San Francisco County and children < 5 years in Alameda and Contra Costa counties); Colorado (5 county Denver area); Connecticut; Georgia (20 county Atlanta area); Maryland (6 county Baltimore area); Minnesota; New Mexico; New York (15 county Rochester and Albany areas and children <5 years in Erie county); Oregon (3 county Portland area); Tennessee (20 counties) ABCs Population The surveillance areas represent 29,757,552 persons. Source: National Center for Health Statistics bridged-race vintage 2010 postcensal file

References

Additional resources about the objective.

  1. Centers for Disease Control and Prevention (CDC). Active Bacterial Core surveillance (ABCs), http://www.cdc.gov/abcs.

About the Data

Description of the data source, numerator, denominator, survey questions, and other relevant details about the national estimate.

National Data Source
Active Bacterial Core Surveillance (ABCS); Centers for Disease Control and Prevention, National Center for Immunization and Respiratory Diseases (CDC/NCIRD)
Changed Since the Healthy People 2020 Launch
Yes
Measure
per 100,000 
Baseline (Year)
8.3 (2008)
Target
6.0
Target-Setting Method
Projection/trend analysis
Numerator
Number of children under age 5 years with a laboratory-confirmed invasive antibiotic-resistant pneumococcal infection in the past 12 months
Denominator
Number of children under age 5 years
Data Collection Frequency
Annual
Comparable Healthy People 2010 Objective
Adapted from HP2010 objective
Methodology Notes

A laboratory-confirmed invasive antibiotic-resistant pneumococcal infection is defined as the isolation of Streptococcus pneumoniae, from a normally sterile site (blood, cerebral spinal fluid, etc.), that is not susceptible to penicillin, amoxicillin, erythromycin, cefotaxime, ceftriaxone, cefuroxime, tetracycline, vancomycin, or levofloxacin according to the 2012 breakpoints defined by the Clinical and Laboratory Standards Institute. Missing race data was multiply imputed and surveillance rates were standardized to the racial distribution of the US population using the NCHS bridged-race vintage 2010 postcensal file.

Caveats and Limitations
ABCs Areas California (San Francisco County and children < 5 years in Alameda and Contra Costa counties); Colorado (5 county Denver area); Connecticut; Georgia (20 county Atlanta area); Maryland (6 county Baltimore area); Minnesota; New Mexico; New York (15 county Rochester and Albany areas and children <5 years in Erie county); Oregon (3 county Portland area); Tennessee (20 counties) ABCs Population The surveillance areas represent 29,757,552 persons. Source: National Center for Health Statistics bridged-race vintage 2010 postcensal file

Revision History

Any change to the objective text, baseline, target, target-setting method or data source since the Healthy People 2020 launch.

Description of Changes Since the Healthy People 2020 Launch

The objective title changed from "Invasive penicillin-resistant pneumococcal infections among children under age 5 years" to "Invasive antibiotic-resistant pneumococcal infections among children under age 5 years." Doctors use many drugs to treat pneumococcal infections. Although penicillin still works well, it is not used often because other drugs can be taken once a day instead of four times a day. To make the HP2020 measure more useful to doctors and patients, CDC would like to include infections that are resistant to several antibiotics, not just penicillin. The numerator definition was revised accordingly. The baseline was recalculated and was revised from 4.3 to 8.2. The target was also recalculated and was revised from 3.0 to 6.0.

References

Additional resources about the objective.

  1. Centers for Disease Control and Prevention (CDC). Active Bacterial Core surveillance (ABCs), http://www.cdc.gov/abcs.

About the Data

Description of the data source, numerator, denominator, survey questions, and other relevant details about the national estimate.

National Data Source
Active Bacterial Core Surveillance (ABCS); Centers for Disease Control and Prevention, National Center for Immunization and Respiratory Diseases (CDC/NCIRD)
Changed Since the Healthy People 2020 Launch
Yes
Measure
per 100,000 
Baseline (Year)
12.2 (2008)
Target
9.0
Target-Setting Method
Projection/trend analysis
Numerator
Number of persons aged 65 years and older with a laboratory-confirmed invasive antibiotic-resistant pneumococcal infection in the past 12 months
Denominator
Number of persons aged 65 years and older
Data Collection Frequency
Annual
Comparable Healthy People 2010 Objective
Adapted from HP2010 objective
Methodology Notes

A laboratory-confirmed invasive antibiotic-resistant pneumococcal infection is defined as the isolation of Streptococcus pneumoniae, from a normally sterile site (blood, cerebral spinal fluid, etc.), that is not susceptible to penicillin, amoxicillin, erythromycin, cefotaxime, ceftriaxone, cefuroxime, tetracycline, vancomycin, or levofloxacin according to the 2012 breakpoints defined by the Clinical and Laboratory Standards Institute. Missing race data was multiply imputed and surveillance rates were standardized to the racial distribution of the US population using the NCHS bridged-race vintage 2010 postcensal file.

Caveats and Limitations
ABCs Areas California (San Francisco County and children < 5 years in Alameda and Contra Costa counties); Colorado (5 county Denver area); Connecticut; Georgia (20 county Atlanta area); Maryland (6 county Baltimore area); Minnesota; New Mexico; New York (15 county Rochester and Albany areas and children <5 years in Erie county); Oregon (3 county Portland area); Tennessee (20 counties) ABCs Population The surveillance areas represent 29,757,552 persons. Source: National Center for Health Statistics bridged-race vintage 2010 postcensal file

Revision History

Any change to the objective text, baseline, target, target-setting method or data source since the Healthy People 2020 launch.

Description of Changes Since the Healthy People 2020 Launch

The objective title changed from "Invasive penicillin-resistant pneumococcal infections among adults aged 65 years and older" to "Invasive antibiotic-resistant pneumococcal infections among adults aged 65 years and older." Doctors use many drugs to treat pneumococcal infections. Although penicillin still works well, it is not used often because other drugs can be taken once a day instead of four times a day. To make the HP2020 measure more useful to doctors and patients, CDC would like to include infections that are resistant to several antibiotics, not just penicillin. The numerator definition was revised accordingly. The baseline was recalculated and was revised from 2.6 to 12.2. The target was also recalculated and was revised from 2.0 to 9.0.

References

Additional resources about the objective.

  1. Centers for Disease Control and Prevention (CDC). Active Bacterial Core surveillance (ABCs), http://www.cdc.gov/abcs.

About the Data

Description of the data source, numerator, denominator, survey questions, and other relevant details about the national estimate.

National Data Source
National Ambulatory Medical Care Survey (NAMCS); Centers for Disease Control and Prevention, National Center for Health Statistics (CDC/NCHS)
National Hospital Ambulatory Medical Care Survey (NHAMCS)
Changed Since the Healthy People 2020 Launch
Yes
Measure
per 100 
Baseline (Year)
48.7 (2006-2007)
Target
37.0
Target-Setting Method
Projection/trend analysis
Numerator
Number of physician visits with an antibiotic course ordered, supplied, administered, or continued among children under age 5 years diagnosed with an ear infection (ICD-9-CM codes 381.0, 381.4, 382.0, 382.4, or 382.9)
Denominator

Number of children under age 5 years diagnosed with an ear infection (ICD-9-CM codes 381.0, 381.4, 382.0, 382.4, or 382.9)

Data Collection Frequency
Biennial
Comparable Healthy People 2010 Objective
Retained from HP2010 objective
Methodology Notes

The number of courses of antibiotics for ear infections among young children (and for the sole diagnosis of the common cold among all ages) are the sum of cases reported by NAMCS and NHAMCS that are listed as any diagnosis (including the primary diagnosis).

FOR MULTIPLE DATA YEARS: Physician office visit rates are calculated based on sum of July 1 estimates of the civilian noninstitutionalized populations for each of the data years involved (e.g., the denominator of a rate for 2006-2007 combined is the sum of the population estimates for 2006 and 2007. The population estimates are from the Vintage matching the data year for the postcensal period based on the 2000 census (e.g., July 1, 2006 civilian noninstitutionalized population estimates from Vintage 2006). July 1, 2010 population estimates based on the 2000 census are used for 2010.

Revision History

Any change to the objective text, baseline, target, target-setting method or data source since the Healthy People 2020 launch.

Description of Changes Since the Healthy People 2020 Launch

The unit of measurement changed from "percent" to "per 100" to be consistent with the objective statement. A phrase was added to the demoninator to clarify the target population which is children with an ear infection: diagnosed with an ear infection (ICD-9-CM codes 381.0, 381.4, 382.0, 382.4, or 382.9). Population Estimates were removed as a data source because population estimates were only used to weight estimates.

References

Additional resources about the objective.

  1. Klein, R.J.; Proctor, S.E.; Boudreault, M.A.; Turczyn, K.M. Healthy People 2010 Criteria for Data Suppression. Statistical Notes No. 24. Hyattsville, MD: National Center for Health Statistics. 2002.

About the Data

Description of the data source, numerator, denominator, survey questions, and other relevant details about the national estimate.

National Data Source
National Ambulatory Medical Care Survey (NAMCS); Centers for Disease Control and Prevention, National Center for Health Statistics (CDC/NCHS)
National Hospital Ambulatory Medical Care Survey (NHAMCS)
Changed Since the Healthy People 2020 Launch
Yes
Measure
per 100,000 
Baseline (Year)
1,458.4 (2006-2007)
Target
756.0
Target-Setting Method
Projection/trend analysis
Numerator

Number of physician visits with antibiotic courses ordered, supplied, administered, or continued among  persons diagnosed with the common cold (ICD-9- CM codes 460.0, 465.0, or 472.0)

Denominator

Number of persons diagnosed with the common cold (ICD-9-CM codes 460.0, 465.0, or 472.0)

Data Collection Frequency
Annual
Comparable Healthy People 2010 Objective
Retained from HP2010 objective
Methodology Notes

The number of courses of antibiotics for the sole diagnosis of the common cold among all ages are the sum of cases reported by NAMCS and NHAMCS that are listed as any diagnosis (including the primary diagnosis).

FOR MULTIPLE DATA YEARS: Physician office visit rates are calculated based on sum of July 1 estimates of the civilian noninstitutionalized populations for each of the data years involved (e.g., the denominator of a rate for 2006-2007 combined is the sum of the population estimates for 2006 and 2007. The population estimates are from the Vintage matching the data year for the postcensal period based on the 2000 census (e.g., July 1, 2006 civilian noninstitutionalized population estimates from Vintage 2006). July 1, 2010 population estimates based on the 2000 census are used for 2010.

Revision History

Any change to the objective text, baseline, target, target-setting method or data source since the Healthy People 2020 launch.

Description of Changes Since the Healthy People 2020 Launch

Population Estimates were removed as a data source because population estimates were only used to weight estimates.

References

Additional resources about the objective.

  1. Klein, R.J.; Proctor, S.E.; Boudreault, M.A.; Turczyn, K.M. Healthy People 2010 Criteria for Data Suppression. Statistical Notes No. 24. Hyattsville, MD: National Center for Health Statistics. 2002.
IID-7 Achieve and maintain effective vaccination coverage levels for universally recommended vaccines among young children

About the Data

Description of the data source, numerator, denominator, survey questions, and other relevant details about the national estimate.

National Data Source
National Immunization Survey (NIS); Centers for Disease Control and Prevention, National Center for Immunization and Respiratory Diseases and National Center for Health Statistics (CDC/NCIRD and CDC/NCHS)
Changed Since the Healthy People 2020 Launch
No
Measure
percent 
Baseline (Year)
84.6 (2008)
Target
90.0
Target-Setting Method
Maintain consistency with national programs, regulations, policies, and laws.
Numerator

Number of children aged 19 to 35 months receiving at least four doses of the combination of diphtheria, tetanus, and acellular pertussis antigens

Denominator

Number of children aged 19 to 35 months

Data Collection Frequency
Annual
Comparable Healthy People 2010 Objective
Retained from HP2010 objective
Methodology Notes

NIS uses a quarterly, random-digit–dialed sample of telephone numbers to reach households with children aged 19–35 months in the 50 states and selected local areas and territories, followed by a mail survey sent to the children's vaccination providers to collect vaccination information. Data were weighted to represent the population of children aged 19–35 months, with adjustments for households with multiple telephone lines and mixed telephone use (landline and cellular), household nonresponse, and exclusion of households without telephone service. Beginning in 2011, surveys included landline and cellular telephone households.

This measure tracks the proportion of children aged 19 to 35 months receiving at least 4 doses of the combination diphtheria, tetanus toxoids and acellular pertussis vaccine, the combination diphtheria, tetanus toxoids, and pertussis vaccine (DTP), or the combination diphtheria and tetanus toxoids vaccine (DT).

References

Additional resources about the objective.

  1. CDC. National and State Vaccination Coverage Among Children Aged 19--35 Months --- United States, 2010. MMWR 2011:60(34):1157-1163. Available from: http://www.cdc.gov/mmwr/preview/mmwrhtml/mm6034a2.htm.
  2. CDC. National, State, and Local Area Vaccination Coverage Among Children Aged 19--35 Months --- United States, 2009. MMWR 2010;59(36):1171-1177. Available from: http://www.cdc.gov/mmwr/preview/mmwrhtml/mm5936a2.htm.
  3. CDC. National, State, and Local Area Vaccination Coverage Among Children Aged 19–35 Months — United States, 2011. MMWR 2012;61(35):689-696. Available from: http://www.cdc.gov/mmwr/preview/mmwrhtml/mm6135a1.htm.

About the Data

Description of the data source, numerator, denominator, survey questions, and other relevant details about the national estimate.

National Data Source
National Immunization Survey (NIS); Centers for Disease Control and Prevention, National Center for Immunization and Respiratory Diseases and National Center for Health Statistics (CDC/NCIRD and CDC/NCHS)
Changed Since the Healthy People 2020 Launch
Yes
Measure
percent 
Baseline (Year)
54.8 (2009)
Target
90.0
Target-Setting Method
Maintain consistency with national programs, regulations, policies, and laws.
Numerator

Number of children aged 19 to 35 months receiving at least 3 or 4 doses of Hib, depending on the vaccine brand

Denominator

Number of children aged 19 to 35 months

Data Collection Frequency
Annual
Comparable Healthy People 2010 Objective
Adapted from HP2010 objective
Methodology Notes

NIS uses a quarterly, random-digit–dialed sample of telephone numbers to reach households with children aged 19–35 months in the 50 states and selected local areas and territories, followed by a mail survey sent to the children's vaccination providers to collect vaccination information. Data were weighted to represent the population of children aged 19–35 months, with adjustments for households with multiple telephone lines and mixed telephone use (landline and cellular), household nonresponse, and exclusion of households without telephone service. Beginning in 2011, surveys included landline and cellular telephone households.

This measure tracks the proportion of children aged 19 to 35 months receiving at least 3 or 4 doses (the full series including the primary series and booster) of the Haemophilus influenzae type b (Hib) vaccine. The number of Hib vaccine doses required differs according to manufacturer (brand). This measure does take into account the brand of vaccine used and assumes that doses with missing Hib type/brand information are a type requiring 4 doses to be up-to-date.

Trend Issues
The baseline estimate is a reflection of the Hib shortage from Dec 2007 to Sept 2009 and the resulting ACIP recommendation to suspend the booster dose of Hib.

Revision History

Any change to the objective text, baseline, target, target-setting method or data source since the Healthy People 2020 launch.

Description of Changes Since the Healthy People 2020 Launch

The baseline was changed from 57 (first two quarters of 2009 data) to 54.8 (2009). The workgroup requested this revision because the 2009 National Immunization Survey (NIS) introduced a new method for measuring Hib vaccination coverage so the survey could distinguish between Hib vaccine product types that require a different number of doses to be fully vaccinated. These 2009 NIS data were not available during the target-setting process in early 2010. The target was not revised. The methodology notes were changed to read: Data collection on the type of Hib vaccine began in January 2009, therefore this baseline estimate is based on data collected in 2009.

References

Additional resources about the objective.

  1. CDC. National and State Vaccination Coverage Among Children Aged 19--35 Months --- United States, 2010. MMWR 2011:60(34):1157-1163. Available from: http://www.cdc.gov/mmwr/preview/mmwrhtml/mm6034a2.htm.
  2. CDC. National, State, and Local Area Vaccination Coverage Among Children Aged 19--35 Months --- United States, 2009. MMWR 2010;59(36):1171-1177. Available from: http://www.cdc.gov/mmwr/preview/mmwrhtml/mm5936a2.htm.
  3. CDC. National, State, and Local Area Vaccination Coverage Among Children Aged 19–35 Months — United States, 2011. MMWR 2012;61(35):689-696. Available from: http://www.cdc.gov/mmwr/preview/mmwrhtml/mm6135a1.htm.

About the Data

Description of the data source, numerator, denominator, survey questions, and other relevant details about the national estimate.

National Data Source
National Immunization Survey (NIS); Centers for Disease Control and Prevention, National Center for Immunization and Respiratory Diseases and National Center for Health Statistics (CDC/NCIRD and CDC/NCHS)
Changed Since the Healthy People 2020 Launch
No
Measure
percent 
Baseline (Year)
93.5 (2008)
Target
90.0
Target-Setting Method
Maintain consistency with national programs, regulations, policies, and laws.
Numerator

Number of children aged 19 to 35 months receiving at least 3 doses of the hepatitis B antigen

Denominator

Number of children aged 19 to 35 months

Data Collection Frequency
Annual
Comparable Healthy People 2010 Objective
Retained from HP2010 objective
Methodology Notes

NIS uses a quarterly, random-digit–dialed sample of telephone numbers to reach households with children aged 19–35 months in the 50 states and selected local areas and territories, followed by a mail survey sent to the children's vaccination providers to collect vaccination information. Data were weighted to represent the population of children aged 19–35 months, with adjustments for households with multiple telephone lines and mixed telephone use (landline and cellular), household nonresponse, and exclusion of households without telephone service. Beginning in 2011, surveys included landline and cellular telephone households.

This measure tracks the proportion of children aged 19 to 35 months receiving at least 3 doses of the hepatitis B (HepB) vaccine.

References

Additional resources about the objective.

  1. CDC. National and State Vaccination Coverage Among Children Aged 19--35 Months --- United States, 2010. MMWR 2011:60(34):1157-1163. Available from: http://www.cdc.gov/mmwr/preview/mmwrhtml/mm6034a2.htm.
  2. CDC. National, State, and Local Area Vaccination Coverage Among Children Aged 19--35 Months --- United States, 2009. MMWR 2010;59(36):1171-1177. Available from: http://www.cdc.gov/mmwr/preview/mmwrhtml/mm5936a2.htm.
  3. CDC. National, State, and Local Area Vaccination Coverage Among Children Aged 19–35 Months — United States, 2011. MMWR 2012;61(35):689-696. Available from: http://www.cdc.gov/mmwr/preview/mmwrhtml/mm6135a1.htm.

About the Data

Description of the data source, numerator, denominator, survey questions, and other relevant details about the national estimate.

National Data Source
National Immunization Survey (NIS); Centers for Disease Control and Prevention, National Center for Immunization and Respiratory Diseases and National Center for Health Statistics (CDC/NCIRD and CDC/NCHS)
Changed Since the Healthy People 2020 Launch
No
Measure
percent 
Baseline (Year)
92.1 (2008)
Target
90.0
Target-Setting Method
Maintain consistency with national programs, regulations, policies, and laws.
Numerator

Number of children aged 19 to 35 months receiving at least 1 dose of the combination of measles, mumps, and rubella antigens

Denominator

Number of children aged 19 to 35 months

Data Collection Frequency
Annual
Comparable Healthy People 2010 Objective
Retained from HP2010 objective
Methodology Notes

NIS uses a quarterly, random-digit–dialed sample of telephone numbers to reach households with children aged 19–35 months in the 50 states and selected local areas and territories, followed by a mail survey sent to the children's vaccination providers to collect vaccination information. Data were weighted to represent the population of children aged 19–35 months, with adjustments for households with multiple telephone lines and mixed telephone use (landline and cellular), household nonresponse, and exclusion of households without telephone service. Beginning in 2011, surveys included landline and cellular telephone households.

This measure tracks the proportion of children aged 19 to 35 months receiving at least 1 dose of the combination measles-mumps-rubella (MMR) vaccine.

References

Additional resources about the objective.

  1. CDC. National and State Vaccination Coverage Among Children Aged 19--35 Months --- United States, 2010. MMWR 2011:60(34):1157-1163. Available from: http://www.cdc.gov/mmwr/preview/mmwrhtml/mm6034a2.htm.
  2. CDC. National, State, and Local Area Vaccination Coverage Among Children Aged 19--35 Months --- United States, 2009. MMWR 2010;59(36):1171-1177. Available from: http://www.cdc.gov/mmwr/preview/mmwrhtml/mm5936a2.htm.
  3. CDC. National, State, and Local Area Vaccination Coverage Among Children Aged 19–35 Months — United States, 2011. MMWR 2012;61(35):689-696. Available from: http://www.cdc.gov/mmwr/preview/mmwrhtml/mm6135a1.htm.

About the Data

Description of the data source, numerator, denominator, survey questions, and other relevant details about the national estimate.

National Data Source
National Immunization Survey (NIS); Centers for Disease Control and Prevention, National Center for Immunization and Respiratory Diseases and National Center for Health Statistics (CDC/NCIRD and CDC/NCHS)
Changed Since the Healthy People 2020 Launch
No
Measure
percent 
Baseline (Year)
93.6 (2008)
Target
90.0
Target-Setting Method
Maintain consistency with national programs, regulations, policies, and laws.
Numerator

Number of children aged 19 to 35 months receiving at least 3 doses of the polio antigen

Denominator

Number of children aged 19 to 35 months

Data Collection Frequency
Annual
Comparable Healthy People 2010 Objective
Retained from HP2010 objective
Methodology Notes

NIS uses a quarterly, random-digit–dialed sample of telephone numbers to reach households with children aged 19–35 months in the 50 states and selected local areas and territories, followed by a mail survey sent to the children's vaccination providers to collect vaccination information. Data were weighted to represent the population of children aged 19–35 months, with adjustments for households with multiple telephone lines and mixed telephone use (landline and cellular), household nonresponse, and exclusion of households without telephone service. Beginning in 2011, surveys included landline and cellular telephone households.

This measure tracks the proportion of children aged 19 to 35 months receiving at least 3 doses of the poliovirus vaccine.

References

Additional resources about the objective.

  1. CDC. National and State Vaccination Coverage Among Children Aged 19--35 Months --- United States, 2010. MMWR 2011:60(34):1157-1163. Available from: http://www.cdc.gov/mmwr/preview/mmwrhtml/mm6034a2.htm.
  2. CDC. National, State, and Local Area Vaccination Coverage Among Children Aged 19--35 Months --- United States, 2009. MMWR 2010;59(36):1171-1177. Available from: http://www.cdc.gov/mmwr/preview/mmwrhtml/mm5936a2.htm.
  3. CDC. National, State, and Local Area Vaccination Coverage Among Children Aged 19–35 Months — United States, 2011. MMWR 2012;61(35):689-696. Available from: http://www.cdc.gov/mmwr/preview/mmwrhtml/mm6135a1.htm.

About the Data

Description of the data source, numerator, denominator, survey questions, and other relevant details about the national estimate.

National Data Source
National Immunization Survey (NIS); Centers for Disease Control and Prevention, National Center for Immunization and Respiratory Diseases and National Center for Health Statistics (CDC/NCIRD and CDC/NCHS)
Changed Since the Healthy People 2020 Launch
No
Measure
percent 
Baseline (Year)
90.7 (2008)
Target
90.0
Target-Setting Method
Maintain consistency with national programs, regulations, policies, and laws.
Numerator

Number of children aged 19 to 35 months receiving at least 1 dose of the varicella antigen

Denominator

Number of children aged 19 to 35 months

Data Collection Frequency
Annual
Comparable Healthy People 2010 Objective
Retained from HP2010 objective
Methodology Notes

NIS uses a quarterly, random-digit–dialed sample of telephone numbers to reach households with children aged 19–35 months in the 50 states and selected local areas and territories, followed by a mail survey sent to the children's vaccination providers to collect vaccination information. Data were weighted to represent the population of children aged 19–35 months, with adjustments for households with multiple telephone lines and mixed telephone use (landline and cellular), household nonresponse, and exclusion of households without telephone service. Beginning in 2011, surveys included landline and cellular telephone households.

This measure tracks the proportion of children aged 19 to 35 months receiving at least 1 dose of the varicella (chickenpox) vaccine.

References

Additional resources about the objective.

  1. CDC. National and State Vaccination Coverage Among Children Aged 19--35 Months --- United States, 2010. MMWR 2011:60(34):1157-1163. Available from: http://www.cdc.gov/mmwr/preview/mmwrhtml/mm6034a2.htm.
  2. CDC. National, State, and Local Area Vaccination Coverage Among Children Aged 19--35 Months --- United States, 2009. MMWR 2010;59(36):1171-1177. Available from: http://www.cdc.gov/mmwr/preview/mmwrhtml/mm5936a2.htm.
  3. CDC. National, State, and Local Area Vaccination Coverage Among Children Aged 19–35 Months — United States, 2011. MMWR 2012;61(35):689-696. Available from: http://www.cdc.gov/mmwr/preview/mmwrhtml/mm6135a1.htm.

About the Data

Description of the data source, numerator, denominator, survey questions, and other relevant details about the national estimate.

National Data Source
National Immunization Survey (NIS); Centers for Disease Control and Prevention, National Center for Immunization and Respiratory Diseases and National Center for Health Statistics (CDC/NCIRD and CDC/NCHS)
Changed Since the Healthy People 2020 Launch
No
Measure
percent 
Baseline (Year)
80.1 (2008)
Target
90.0
Target-Setting Method
Maintain consistency with national programs, regulations, policies, and laws.
Numerator

Number of children aged 19 to 35 months receiving at least 4 doses of the pneumococcal conjugate vaccine

Denominator

Number of children aged 19 to 35 months

Data Collection Frequency
Annual
Comparable Healthy People 2010 Objective
Retained from HP2010 objective
Methodology Notes

NIS uses a quarterly, random-digit–dialed sample of telephone numbers to reach households with children aged 19–35 months in the 50 states and selected local areas and territories, followed by a mail survey sent to the children's vaccination providers to collect vaccination information. Data were weighted to represent the population of children aged 19–35 months, with adjustments for households with multiple telephone lines and mixed telephone use (landline and cellular), household nonresponse, and exclusion of households without telephone service. Beginning in 2011, surveys included landline and cellular telephone households.

This measure tracks the proportion of children aged 19 to 35 months receiving at least 4 doses of the pneumococcal conjugate vaccine (PCV).

References

Additional resources about the objective.

  1. CDC. National and State Vaccination Coverage Among Children Aged 19--35 Months --- United States, 2010. MMWR 2011:60(34):1157-1163. Available from: http://www.cdc.gov/mmwr/preview/mmwrhtml/mm6034a2.htm.
  2. CDC. National, State, and Local Area Vaccination Coverage Among Children Aged 19--35 Months --- United States, 2009. MMWR 2010;59(36):1171-1177. Available from: http://www.cdc.gov/mmwr/preview/mmwrhtml/mm5936a2.htm.
  3. CDC. National, State, and Local Area Vaccination Coverage Among Children Aged 19–35 Months — United States, 2011. MMWR 2012;61(35):689-696. Available from: http://www.cdc.gov/mmwr/preview/mmwrhtml/mm6135a1.htm.

About the Data

Description of the data source, numerator, denominator, survey questions, and other relevant details about the national estimate.

National Data Source
National Immunization Survey (NIS); Centers for Disease Control and Prevention, National Center for Immunization and Respiratory Diseases and National Center for Health Statistics (CDC/NCIRD and CDC/NCHS)
Changed Since the Healthy People 2020 Launch
No
Measure
percent 
Baseline (Year)
40.4 (2008)
Target
85.0
Target-Setting Method
Maintain consistency with national programs, regulations, policies, and laws.
Numerator

Number of children aged 19 to 35 months receiving at least 2 doses of Hepatitis A vaccine

Denominator

Number of children aged 19 to 35 months

Data Collection Frequency
Annual
Comparable Healthy People 2010 Objective
Not applicable
Methodology Notes

NIS uses a quarterly, random-digit–dialed sample of telephone numbers to reach households with children aged 19–35 months in the 50 states and selected local areas and territories, followed by a mail survey sent to the children's vaccination providers to collect vaccination information. Data were weighted to represent the population of children aged 19–35 months, with adjustments for households with multiple telephone lines and mixed telephone use (landline and cellular), household nonresponse, and exclusion of households without telephone service. Beginning in 2011, surveys included landline and cellular telephone households.

This measure tracks the proportion of children aged 19 to 35 months receiving at least 2 doses of the hepatitis A (HepA) vaccine.

References

Additional resources about the objective.

  1. CDC. National and State Vaccination Coverage Among Children Aged 19--35 Months --- United States, 2010. MMWR 2011:60(34):1157-1163. Available from: http://www.cdc.gov/mmwr/preview/mmwrhtml/mm6034a2.htm.
  2. CDC. National, State, and Local Area Vaccination Coverage Among Children Aged 19--35 Months --- United States, 2009. MMWR 2010;59(36):1171-1177. Available from: http://www.cdc.gov/mmwr/preview/mmwrhtml/mm5936a2.htm.
  3. CDC. National, State, and Local Area Vaccination Coverage Among Children Aged 19–35 Months — United States, 2011. MMWR 2012;61(35):689-696. Available from: http://www.cdc.gov/mmwr/preview/mmwrhtml/mm6135a1.htm.

About the Data

Description of the data source, numerator, denominator, survey questions, and other relevant details about the national estimate.

National Data Source
National Immunization Survey (NIS); Centers for Disease Control and Prevention, National Center for Immunization and Respiratory Diseases and National Center for Health Statistics (CDC/NCIRD and CDC/NCHS)
Changed Since the Healthy People 2020 Launch
No
Measure
percent 
Baseline (Year)
50.9 (2006-2008)
Target
85.0
Target-Setting Method
Maintain consistency with national programs, regulations, policies, and laws.
Numerator
Number of children who received the first dose of hepatitis B vaccine within three days of birth
Denominator

Number of children in the birth cohort

Data Collection Frequency
Annual
Comparable Healthy People 2010 Objective
Not applicable
Methodology Notes

NIS uses a quarterly, random-digit–dialed sample of telephone numbers to reach households with children aged 19–35 months in the 50 states and selected local areas and territories, followed by a mail survey sent to the children's vaccination providers to collect vaccination information. Data were weighted to represent the population of children aged 19–35 months, with adjustments for households with multiple telephone lines and mixed telephone use (landline and cellular), household nonresponse, and exclusion of households without telephone service. Beginning in 2011, surveys included landline and cellular telephone households.

This measure tracks the proportion of children aged 0 to 3 days receiving at least a single birth dose of hepatitis B vaccine (calculated as the date of vaccination minus the child's birth date). Data for children in a given birth cohort are obtained from data collected during the ensuing 3 year period. For example, data for children born in 2005 were gathered in the 2006-2008 NIS surveys.

References

Additional resources about the objective.

  1. CDC. National and State Vaccination Coverage Among Children Aged 19--35 Months --- United States, 2010. MMWR 2011:60(34):1157-1163. Available from: http://www.cdc.gov/mmwr/preview/mmwrhtml/mm6034a2.htm.
  2. CDC. National, State, and Local Area Vaccination Coverage Among Children Aged 19--35 Months --- United States, 2009. MMWR 2010;59(36):1171-1177. Available from: http://www.cdc.gov/mmwr/preview/mmwrhtml/mm5936a2.htm.
  3. CDC. National, State, and Local Area Vaccination Coverage Among Children Aged 19–35 Months — United States, 2011. MMWR 2012;61(35):689-696. Available from: http://www.cdc.gov/mmwr/preview/mmwrhtml/mm6135a1.htm.

About the Data

Description of the data source, numerator, denominator, survey questions, and other relevant details about the national estimate.

National Data Source
National Immunization Survey (NIS); Centers for Disease Control and Prevention, National Center for Immunization and Respiratory Diseases and National Center for Health Statistics (CDC/NCIRD and CDC/NCHS)
Changed Since the Healthy People 2020 Launch
No
Measure
percent 
Baseline (Year)
43.9 (2009)
Target
80.0
Target-Setting Method
Maintain consistency with national programs, regulations, policies, and laws.
Numerator

Number of children aged 19 to 35 months receiving at least 2 or 3 doses of rotavirus vaccine, depending on the vaccine brand

Denominator

Number of children aged 19 to 35 months

Data Collection Frequency
Annual
Comparable Healthy People 2010 Objective
Not applicable
Methodology Notes

NIS uses a quarterly, random-digit–dialed sample of telephone numbers to reach households with children aged 19–35 months in the 50 states and selected local areas and territories, followed by a mail survey sent to the children's vaccination providers to collect vaccination information. Data were weighted to represent the population of children aged 19–35 months, with adjustments for households with multiple telephone lines and mixed telephone use (landline and cellular), household nonresponse, and exclusion of households without telephone service. Beginning in 2011, surveys included landline and cellular telephone households.

This measure tracks the proportion of children aged 19 to 35 months receiving at least 2 or 3 doses of the rotavirus vaccine. The number of rotavirus vaccine doses required differs according to manufacturer (brand). This measure does take into account the brand of vaccine used and assumes that doses with missing rotavirus type/brand information are a type requiring 3 doses to be up-to-date.

References

Additional resources about the objective.

  1. CDC. National and State Vaccination Coverage Among Children Aged 19--35 Months --- United States, 2010. MMWR 2011:60(34):1157-1163. Available from: http://www.cdc.gov/mmwr/preview/mmwrhtml/mm6034a2.htm.
  2. CDC. National, State, and Local Area Vaccination Coverage Among Children Aged 19--35 Months --- United States, 2009. MMWR 2010;59(36):1171-1177. Available from: http://www.cdc.gov/mmwr/preview/mmwrhtml/mm5936a2.htm.
  3. CDC. National, State, and Local Area Vaccination Coverage Among Children Aged 19–35 Months — United States, 2011. MMWR 2012;61(35):689-696. Available from: http://www.cdc.gov/mmwr/preview/mmwrhtml/mm6135a1.htm.
IID-8 Increase the percentage of children aged 19 to 35 months who receive the recommended doses of DTaP, polio, MMR, Hib, hepatitis B, varicella and pneumococcal conjugate vaccine (PCV) Leading Health Indicators

Leading Health Indicators are a subset of Healthy People 2020 objectives selected to communicate high-priority health issues.

About the Data

Description of the data source, numerator, denominator, survey questions, and other relevant details about the national estimate.

National Data Source
National Immunization Survey (NIS); Centers for Disease Control and Prevention, National Center for Immunization and Respiratory Diseases and National Center for Health Statistics (CDC/NCIRD and CDC/NCHS)
Changed Since the Healthy People 2020 Launch
Yes
Measure
percent 
Baseline (Year)
44.3 (2009)
Target
80.0
Target-Setting Method
Maintain consistency with national programs, regulations, policies, and laws.
Numerator

Number of children aged 19 to 35 months receiving at least four doses of diphtheria-tetanus-acellular pertussis (DTaP), at least three doses of polio, at least one dose of measles-containing vaccine, at least three or four doses of Haemophilus influenzae B (Hib) depending on the brand used, at least three doses of hepatitis B antigens, at least one dose of varicella, and at least four doses of PCV

Denominator

Number of children aged 19 to 35 months

Data Collection Frequency
Annual
Comparable Healthy People 2010 Objective
Adapted from HP2010 objective
Leading Health Indicator
Clinical Preventive Services
Methodology Notes

NIS uses a quarterly, random-digit–dialed sample of telephone numbers to reach households with children aged 19–35 months in the 50 states and selected local areas and territories, followed by a mail survey sent to the children's vaccination providers to collect vaccination information. Data were weighted to represent the population of children aged 19–35 months, with adjustments for households with multiple telephone lines and mixed telephone use (landline and cellular), household nonresponse, and exclusion of households without telephone service. Beginning in 2011, surveys included landline and cellular telephone households.

This measure tracks the proportion of children aged 19 to 35 months receiving the routine series of recommended vaccinations, refered to as 4:3:1:3:3:1:4 series. This series includes at least four doses of diphtheria-tetanus-acellular pertussis (DTaP), at least three doses of polio, at least one dose of measles-containing vaccine, at least three or four doses of Haemophilus influenzae B (Hib) vaccine depending on the brand used, at least three doses of hepatitis B, at least one dose of varicella antigens, and at least 4 doses of pneumococcal conjugate vaccine (PCV). The number of Hib vaccine doses required differs according to manufacturer (brand). This measure does take into account the brand of vaccine used and assumes that doses with missing Hib type/brand information are a type requiring 4 doses to be up-to-date.

Trend Issues
The baseline estimate is a reflection of the Hib shortage from Dec 2007 to Sept 2009 and the resulting ACIP recommendation to suspend the booster dose of Hib.

Revision History

Any change to the objective text, baseline, target, target-setting method or data source since the Healthy People 2020 launch.

Description of Changes Since the Healthy People 2020 Launch

The baseline was revised from 68 (2008) to 44.3 (2009). The workgroup made this revision because the 2009 National Immunization Survey (NIS) introduced a new method for measuring Hib vaccination coverage so the survey could distinguish between Hib vaccine product types that require a different number of doses to be fully vaccinated. These 2009 NIS data were not available during the target-setting process in early 2010. The target was not revised.

References

Additional resources about the objective.

  1. CDC. National and State Vaccination Coverage Among Children Aged 19--35 Months --- United States, 2010. MMWR 2011:60(34):1157-1163. Available from: http://www.cdc.gov/mmwr/preview/mmwrhtml/mm6034a2.htm.
  2. CDC. National, State, and Local Area Vaccination Coverage Among Children Aged 19--35 Months --- United States, 2009. MMWR 2010;59(36):1171-1177. Available from: http://www.cdc.gov/mmwr/preview/mmwrhtml/mm5936a2.htm.
  3. CDC. National, State, and Local Area Vaccination Coverage Among Children Aged 19–35 Months — United States, 2011. MMWR 2012;61(35):689-696. Available from: http://www.cdc.gov/mmwr/preview/mmwrhtml/mm6135a1.htm.

About the Data

Description of the data source, numerator, denominator, survey questions, and other relevant details about the national estimate.

National Data Source
National Immunization Survey (NIS); Centers for Disease Control and Prevention, National Center for Immunization and Respiratory Diseases and National Center for Health Statistics (CDC/NCIRD and CDC/NCHS)
Changed Since the Healthy People 2020 Launch
No
Measure
percent 
Baseline (Year)
0.6 (2008)
Target
Not applicable
Target-Setting Method
This measure is being tracked for informational purposes. If warranted, a target will be set during the decade.
Numerator

Number of children aged 19 to 35 months who receive zero doses of any recommended vaccines (including DTaP, Hib, measles-containing vaccine, polio, HepB, varicella, PCV, HepA, rotavirus, or influenza)

Denominator

Number of children aged 19 to 35 months

Data Collection Frequency
Annual
Comparable Healthy People 2010 Objective
Not applicable
Methodology Notes

NIS uses a quarterly, random-digit–dialed sample of telephone numbers to reach households with children aged 19–35 months in the 50 states and selected local areas and territories, followed by a mail survey sent to the children's vaccination providers to collect vaccination information. Data were weighted to represent the population of children aged 19–35 months, with adjustments for households with multiple telephone lines and mixed telephone use (landline and cellular), household nonresponse, and exclusion of households without telephone service. Beginning in 2011, surveys included landline and cellular telephone households.

This measure tracks the proportion of children aged 19 to 35 months receiving zero doses of any recommended vaccines (including DTaP, Hib, measles-containing vaccine, polio, HepB, varicella, PCV, HepA, rotavirus, or influenza).

References

Additional resources about the objective.

  1. CDC. National and State Vaccination Coverage Among Children Aged 19--35 Months --- United States, 2010. MMWR 2011:60(34):1157-1163. Available from: http://www.cdc.gov/mmwr/preview/mmwrhtml/mm6034a2.htm.
  2. CDC. National, State, and Local Area Vaccination Coverage Among Children Aged 19--35 Months --- United States, 2009. MMWR 2010;59(36):1171-1177. Available from: http://www.cdc.gov/mmwr/preview/mmwrhtml/mm5936a2.htm.
  3. CDC. National, State, and Local Area Vaccination Coverage Among Children Aged 19–35 Months — United States, 2011. MMWR 2012;61(35):689-696. Available from: http://www.cdc.gov/mmwr/preview/mmwrhtml/mm6135a1.htm.
IID-10 Maintain vaccination coverage levels for children in kindergarten

About the Data

Description of the data source, numerator, denominator, survey questions, and other relevant details about the national estimate.

National Data Source
Annual School Assessment Reports; Centers for Disease Control and Prevention, National Center for Immunization and Respiratory Diseases (CDC/NCIRD)
Changed Since the Healthy People 2020 Launch
Yes
Measure
percent 
Baseline (Year)
97.2 (2009-2010)
Target
95.0
Target-Setting Method
Maintain consistency with national programs, regulations, policies, and laws.
Numerator
Number of surveyed enrollees in kindergarten who received 4 or more doses of DTaP vaccine
Denominator
Number of surveyed enrollees in kindergarten during the survey school year
Data Collection Frequency
Annual
Comparable Healthy People 2010 Objective
Adapted from HP2010 objective
Methodology Notes

Data reflect the median of state vaccination coverage estimates. Estimates are obtained by combining states’ estimates and weighting the vaccine-specific coverage levels reported by states and territories to their respective birth cohorts. Data are provided for a school year and reflect vaccination status at entry into school. For example, vaccination for the 2009-10 school year reflects vaccination coverage for kindergarteners as of start of the school year in 2009. States may collect and/or report data on selective antigens depending upon school entry requirements.

Caveats and Limitations
Sampling methodology vary by state, which is a major limitation (e.g., some states selected a random sample of kindergarten children and others conducted a census of all kindergarten children).

Revision History

Any change to the objective text, baseline, target, target-setting method or data source since the Healthy People 2020 launch.

Description of Changes Since the Healthy People 2020 Launch

The baseline total was revised from 95.0 (2007-2008) to 97.2 (2009-2010) because data prior to 2009-2010 could not be appropriately weighted and verified. The target was not revised.

About the Data

Description of the data source, numerator, denominator, survey questions, and other relevant details about the national estimate.

National Data Source
Annual School Assessment Reports; Centers for Disease Control and Prevention, National Center for Immunization and Respiratory Diseases (CDC/NCIRD)
Changed Since the Healthy People 2020 Launch
Yes
Measure
percent 
Baseline (Year)
95.0 (2009-2010)
Target
95.0
Target-Setting Method
Maintain consistency with national programs, regulations, policies, and laws.
Numerator
Number of surveyed enrollees in kindergarten who received 2 or more doses of MMR vaccine
Denominator
Number of surveyed enrollees in kindergarten during the survey year
Data Collection Frequency
Annual
Comparable Healthy People 2010 Objective
Adapted from HP2010 objective
Methodology Notes

Data reflect the median of state vaccination coverage estimates. Estimates are obtained by combining states’ estimates and weighting the vaccine-specific coverage levels reported by states and territories to their respective birth cohorts. Data are provided for a school year and reflect vaccination status at entry into school. For example, vaccination for the 2009-10 school year reflects vaccination coverage for kindergarteners as of start of the school year in 2009. States may collect and/or report data on selective antigens depending upon school entry requirements.

Caveats and Limitations
Sampling methodology vary by state, which is a major limitation (e.g., some states selected a random sample of kindergarten children and others conducted a census of all kindergarten children).

Revision History

Any change to the objective text, baseline, target, target-setting method or data source since the Healthy People 2020 launch.

Description of Changes Since the Healthy People 2020 Launch

The baseline total was revised from 95.0 (2007-2008) to 95.0 (2009-2010) because data prior to 2009-2010 could not be appropriately weighted and verified. The target was not revised.

About the Data

Description of the data source, numerator, denominator, survey questions, and other relevant details about the national estimate.

National Data Source
Annual School Assessment Reports; Centers for Disease Control and Prevention, National Center for Immunization and Respiratory Diseases (CDC/NCIRD)
Changed Since the Healthy People 2020 Launch
Yes
Measure
percent 
Baseline (Year)
96.2 (2009-2010)
Target
95.0
Target-Setting Method
Maintain consistency with national programs, regulations, policies, and laws.
Numerator
Number of surveyed enrollees in kindergarten who received 3 or more doses of polio vaccine
Denominator
Number of surveyed enrollees in kindergarten during the survey school year
Data Collection Frequency
Annual
Comparable Healthy People 2010 Objective
Adapted from HP2010 objective
Methodology Notes

Data reflect the median of state vaccination coverage estimates. Estimates are obtained by combining states’ estimates and weighting the vaccine-specific coverage levels reported by states and territories to their respective birth cohorts. Data are provided for a school year and reflect vaccination status at entry into school. For example, vaccination for the 2009-10 school year reflects vaccination coverage for kindergarteners as of start of the school year in 2009. States may collect and/or report data on selective antigens depending upon school entry requirements.

Caveats and Limitations
Sampling methodology vary by state, which is a major limitation (e.g., some states selected a random sample of kindergarten children and others conducted a census of all kindergarten children).

Revision History

Any change to the objective text, baseline, target, target-setting method or data source since the Healthy People 2020 launch.

Description of Changes Since the Healthy People 2020 Launch

The baseline total was revised from 96.0 (2007-2008) to 96.2 (2009-2010) because data prior to 2009-2010 could not be appropriately weighted and verified. The target was not revised.

About the Data

Description of the data source, numerator, denominator, survey questions, and other relevant details about the national estimate.

National Data Source
Annual School Assessment Reports; Centers for Disease Control and Prevention, National Center for Immunization and Respiratory Diseases (CDC/NCIRD)
Changed Since the Healthy People 2020 Launch
Yes
Measure
percent 
Baseline (Year)
97.0 (2009-2010)
Target
95.0
Target-Setting Method
Maintain consistency with national programs, regulations, policies, and laws.
Numerator
Number of surveyed enrollees in kindergarten who received 3 or more doses of hepatitis B vaccine
Denominator
Number of surveyed enrollees in kindergarten during the survey year
Data Collection Frequency
Annual
Comparable Healthy People 2010 Objective
Adapted from HP2010 objective
Methodology Notes

Data reflect the median of state vaccination coverage estimates. Estimates are obtained by combining states’ estimates and weighting the vaccine-specific coverage levels reported by states and territories to their respective birth cohorts. Data are provided for a school year and reflect vaccination status at entry into school. For example, vaccination for the 2009-10 school year reflects vaccination coverage for kindergarteners as of start of the school year in 2009. States may collect and/or report data on selective antigens depending upon school entry requirements.

Caveats and Limitations
Sampling methodology vary by state, which is a major limitation (e.g., some states selected a random sample of kindergarten children and others conducted a census of all kindergarten children).

Revision History

Any change to the objective text, baseline, target, target-setting method or data source since the Healthy People 2020 launch.

Description of Changes Since the Healthy People 2020 Launch

The baseline total was revised from 96.0 (2007-2008) to 97.0 (2009-2010) because data prior to 2009-2010 could not be appropriately weighted and verified. The target was not revised.

About the Data

Description of the data source, numerator, denominator, survey questions, and other relevant details about the national estimate.

National Data Source
Annual School Assessment Reports; Centers for Disease Control and Prevention, National Center for Immunization and Respiratory Diseases (CDC/NCIRD)
Changed Since the Healthy People 2020 Launch
Yes
Measure
percent 
Baseline (Year)
91.3 (2009-2010)
Target
95.0
Target-Setting Method
Maintain consistency with national programs, regulations, policies, and laws.
Numerator
Number of surveyed enrollees in kindergarten who received 2 or more doses of varicella vaccine
Denominator
Number of surveyed enrollees in kindergarten during the survey school year
Data Collection Frequency
Annual
Comparable Healthy People 2010 Objective
Adapted from HP2010 objective
Methodology Notes

Data reflect the median of state vaccination coverage estimates. Estimates are obtained by combining states’ estimates and weighting the vaccine-specific coverage levels reported by states and territories to their respective birth cohorts. Data are provided for a school year and reflect vaccination status at entry into school. For example, vaccination for the 2009-10 school year reflects vaccination coverage for kindergarteners as of start of the school year in 2009. States may collect and/or report data on selective antigens depending upon school entry requirements.

Caveats and Limitations
Sampling methodology vary by state, which is a major limitation (e.g., some states selected a random sample of kindergarten children and others conducted a census of all kindergarten children).

Revision History

Any change to the objective text, baseline, target, target-setting method or data source since the Healthy People 2020 launch.

Description of Changes Since the Healthy People 2020 Launch

The baseline total was revised from 94.0 (2007-2008) to 91.3 (2009-2010) because data prior to 2009-2010 could not be appropriately weighted and verified. The target was not revised.

IID-11 Increase routine vaccination coverage levels for adolescents

About the Data

Description of the data source, numerator, denominator, survey questions, and other relevant details about the national estimate.

National Data Source
National Immunization Survey (NIS); Centers for Disease Control and Prevention, National Center for Immunization and Respiratory Diseases and National Center for Health Statistics (CDC/NCIRD and CDC/NCHS)
Changed Since the Healthy People 2020 Launch
No
Measure
percent 
Baseline (Year)
46.7 (2008)
Target
80.0
Target-Setting Method
Maintain consistency with national programs, regulations, policies, and laws.
Numerator

Number of persons aged 13 to 15 years receiving at least 1 dose of a tetanus-diphtheria-acelluar pertussis (Tdap) booster vaccine

Denominator

Number of persons aged 13 to 15 years

Data Collection Frequency
Annual
Comparable Healthy People 2010 Objective
Adapted from HP2010 objective
Methodology Notes

NIS-Teen collects vaccination information for adolescents aged 13–17 years in the 50 states, the District of Columbia, selected areas, and the U.S. Virgin Islands, using a random-digit–dialed sample of landline and, starting in 2011, cellular telephone numbers. Parent/guardian respondents provide vaccination and sociodemographic information on adolescents in their care. After the parent/guardian grants permission to contact their child's vaccination provider, a questionnaire is mailed to that provider to obtain a vaccination history from the medical record. Data for this measure were restricted to adolescents aged 13–15 and weighted to represent the population of adolescents age 13-15, with adjustments for households with multiple telephone lines and mixed telephone use (landline and cellular), household nonresponse, and exclusion of households without telephone service.

In 2006, the Advisory Committee on Immunization Practices (ACIP) recommended that 1) adolescents aged 11--18 years should receive a single dose of Tdap for booster immunization if they had completed the recommended childhood DTP/DTaP vaccination series and have not received Td or Tdap; 2) adolescents aged 11--18 years who received Td, but not Tdap, are encouraged to receive a single dose of Tdap to provide protection against pertussis if they have completed the recommended childhood DTP/DTaP vaccination series; and 3) vaccine providers should administer Tdap and tetravalent meningococcal conjugate vaccine (tracked in Healthy People objective to adolescents aged 11--18 years during the same visit if both vaccines are indicated and available. In 2010, ACIP approved the following additional recommendations: 1) use of Tdap regardless of interval since the last tetanus- or diphtheria-toxoid containing vaccine, 2) use of Tdap in certain adults aged 65 years and older, and 3) use of Tdap in undervaccinated children aged 7 through 10 years.

This measure tracks the proportion of adolescents aged 13–15 years receiving at least 1 dose of tetanus toxoid, reduced diphtheria toxoid, and acellular pertussis (Tdap) since the age of ten years.

References

Additional resources about the objective.

  1. Datasets for the National Immunization Survey - Teen [online]. Atlanta (GA): National Center for Immunization and Respiratory Diseases. c2013 – [cited 2013 June 6]. Available from: http://www.cdc.gov/nchs/nis/data_files_teen.htm.

About the Data

Description of the data source, numerator, denominator, survey questions, and other relevant details about the national estimate.

National Data Source
National Immunization Survey (NIS); Centers for Disease Control and Prevention, National Center for Immunization and Respiratory Diseases and National Center for Health Statistics (CDC/NCIRD and CDC/NCHS)
Changed Since the Healthy People 2020 Launch
No
Measure
percent 
Baseline (Year)
36.7 (2008)
Target
90.0
Target-Setting Method
Maintain consistency with national programs, regulations, policies, and laws.
Numerator

Number of persons aged 13 to 15 years receiving at least 2 doses of varicella (excluding those who have had varicella)

Denominator

Number of persons aged 13 to 15 years (excluding those who have had varicella)

Data Collection Frequency
Annual
Comparable Healthy People 2010 Objective
Adapted from HP2010 objective
Methodology Notes

NIS-Teen collects vaccination information for adolescents aged 13–17 years in the 50 states, the District of Columbia, selected areas, and the U.S. Virgin Islands, using a random-digit–dialed sample of landline and, starting in 2011, cellular telephone numbers. Parent/guardian respondents provide vaccination and sociodemographic information on adolescents in their care. After the parent/guardian grants permission to contact their child's vaccination provider, a questionnaire is mailed to that provider to obtain a vaccination history from the medical record. Data for this measure were restricted to adolescents aged 13–15 and weighted to represent the population of adolescents age 13-15, with adjustments for households with multiple telephone lines and mixed telephone use (landline and cellular), household nonresponse, and exclusion of households without telephone service.

In 2005, the Advisory Committee on Immunization Practices (ACIP) recommended 1) a routine 2-dose varicella vaccination program for children, with the first dose administered at age 12-15 months and the second dose at age 4-6 years; and 2) a second dose catch-up varicella vaccination for children, adolescents, and adults who previously had received 1 dose.

This measure tracks the proportion of adolescents aged 13–15 years receiving at least 2 doses of the varicella vaccine among those who have not had varicella disease.

References

Additional resources about the objective.

  1. Datasets for the National Immunization Survey - Teen [online]. Atlanta (GA): National Center for Immunization and Respiratory Diseases. c2013 – [cited 2013 June 6]. Available from: http://www.cdc.gov/nchs/nis/data_files_teen.htm.

About the Data

Description of the data source, numerator, denominator, survey questions, and other relevant details about the national estimate.

National Data Source
National Immunization Survey (NIS); Centers for Disease Control and Prevention, National Center for Immunization and Respiratory Diseases and National Center for Health Statistics (CDC/NCIRD and CDC/NCHS)
Changed Since the Healthy People 2020 Launch
No
Measure
percent 
Baseline (Year)
43.9 (2008)
Target
80.0
Target-Setting Method
Maintain consistency with national programs, regulations, policies, and laws.
Numerator

Number of persons aged 13 to 15 years receiving at least 1 dose of meningococcal conjugate vaccine

Denominator

Number of persons aged 13 to 15 years

Data Collection Frequency
Annual
Comparable Healthy People 2010 Objective
Not applicable
Methodology Notes

NIS-Teen collects vaccination information for adolescents aged 13–17 years in the 50 states, the District of Columbia, selected areas, and the U.S. Virgin Islands, using a random-digit–dialed sample of landline and, starting in 2011, cellular telephone numbers. Parent/guardian respondents provide vaccination and sociodemographic information on adolescents in their care. After the parent/guardian grants permission to contact their child's vaccination provider, a questionnaire is mailed to that provider to obtain a vaccination history from the medical record. Data for this measure were restricted to adolescents aged 13–15 and weighted to represent the population of adolescents age 13-15, with adjustments for households with multiple telephone lines and mixed telephone use (landline and cellular), household nonresponse, and exclusion of households without telephone service.

In 2005, the Advisory Committee on Immunization Practices (ACIP) recommended the routine vaccination of adolescents aged 11-12 years at the preadolescent health care visit and for adolescents before high school entry. In 2008, the ACIP expanded its recommendations to the routine administration of meningococcal vaccine at 11-12 years of age and 13-18 years of age if not previously vaccinated. In 2011, the ACIP recommended that a single dose of vaccine be administered at age 11 or 12 years, with a booster dose at age 16 years for persons who receive the first dose before age 16 years.

This measure tracks the proportion of adolescents aged 13–15 years receiving at least 1 of the meningococcal conjugate vaccine (MenACWY) and meningococcal-unknown type vaccine.

References

Additional resources about the objective.

  1. Datasets for the National Immunization Survey - Teen [online]. Atlanta (GA): National Center for Immunization and Respiratory Diseases. c2013 – [cited 2013 June 6]. Available from: http://www.cdc.gov/nchs/nis/data_files_teen.htm.

About the Data

Description of the data source, numerator, denominator, survey questions, and other relevant details about the national estimate.

National Data Source
National Immunization Survey (NIS); Centers for Disease Control and Prevention, National Center for Immunization and Respiratory Diseases and National Center for Health Statistics (CDC/NCIRD and CDC/NCHS)
Changed Since the Healthy People 2020 Launch
No
Measure
percent 
Baseline (Year)
16.6 (2008)
Target
80.0
Target-Setting Method
Maintain consistency with national programs, regulations, policies, and laws.
Numerator

Number of females aged 13 to 15 years receiving at least 3 doses of the human papillomavirus (HPV) vaccine

Denominator

Number of females aged 13 to 15 years

Data Collection Frequency
Annual
Comparable Healthy People 2010 Objective
Not applicable
Methodology Notes

NIS-Teen collects vaccination information for adolescents aged 13–17 years in the 50 states, the District of Columbia, selected areas, and the U.S. Virgin Islands, using a random-digit–dialed sample of landline and, starting in 2011, cellular telephone numbers. Parent/guardian respondents provide vaccination and sociodemographic information on adolescents in their care. After the parent/guardian grants permission to contact their child's vaccination provider, a questionnaire is mailed to that provider to obtain a vaccination history from the medical record. Data for this measure were restricted to adolescents aged 13–15 and weighted to represent the population of adolescents age 13-15, with adjustments for households with multiple telephone lines and mixed telephone use (landline and cellular), household nonresponse, and exclusion of households without telephone service.

In 2007, the Advisory Committing on Immunization Practices (ACIP) recommended a routine 3-dose series of human papillomavirus vaccination for females age 11-12 years and catch-up vaccination for females aged 13-26 years who have not been previously vaccinated. The vaccination may be initiated as early as nine years of age and should be administered before potential exposure to HPV through sexual contact.

This measure tracks the proportion of female adolescents aged 13–15 years receiving at least 3 doses of the quadrivalent or bivalent human papillomavirus vaccine.

Caveats and Limitations
This measure does not track HPV vaccine coverage among males. ACIP began recommending this vaccine among males in 2011.

References

Additional resources about the objective.

  1. Datasets for the National Immunization Survey - Teen [online]. Atlanta (GA): National Center for Immunization and Respiratory Diseases. c2013 – [cited 2013 June 6]. Available from: http://www.cdc.gov/nchs/nis/data_files_teen.htm.
IID-12 Increase the percentage of children and adults who are vaccinated annually against seasonal influenza

About the Data

Description of the data source, numerator, denominator, survey questions, and other relevant details about the national estimate.

National Data Source
National Immunization Survey (NIS); Centers for Disease Control and Prevention, National Center for Immunization and Respiratory Diseases and National Center for Health Statistics (CDC/NCIRD and CDC/NCHS)
Changed Since the Healthy People 2020 Launch
Yes
Measure
percent 
Baseline (Year)
23.4 (2008)
Target
80.0
Target-Setting Method
Maintain consistency with national programs, regulations, policies, and laws.
Numerator
Number of children aged 6 to 23 months fully vaccinated (1, 2, or more doses) with influenza vaccine in the NIS sample
Denominator
The subset of children aged 6 to 23 months during the beginning of the influenza season (September-December) within the NIS sample of children aged 19-35 months at the time of the household interview
Comparable Healthy People 2010 Objective
Adapted from HP2010 objective
Methodology Notes

Only children in the NIS sample aged 6-23 months during the entire span of September-December are included in the measure.

Children in the NIS sample are 19-35 months at the time of the interview. Children’s entire history of influenza vaccination is obtained. Only provider reported vaccinations are used for NIS estimates.

Revision History

Any change to the objective text, baseline, target, target-setting method or data source since the Healthy People 2020 launch.

Description of Changes Since the Healthy People 2020 Launch

In 2013, objectives IID-12.1 through 12.4 objectives were consolidated and revised to IID-12.11.

References

Additional resources about the objective.

  1. Klein, R.J.; Proctor, S.E.; Boudreault, M.A.; Turczyn, K.M. Healthy People 2010 Criteria for Data Suppression. Statistical Notes No. 24. Hyattsville, MD: National Center for Health Statistics. 2002.

About the Data

Description of the data source, numerator, denominator, survey questions, and other relevant details about the national estimate.

National Data Source
National Health Interview Survey (NHIS); Centers for Disease Control and Prevention, National Center for Health Statistics (CDC/NCHS)
Changed Since the Healthy People 2020 Launch
Yes
Measure
percent 
Baseline (Year)
39.6 (2008)
Target
80.0
Target-Setting Method
Maintain consistency with national programs, regulations, policies, and laws.
Numerator
Number of children aged 2 to 4 years who receive 1 dose of influenza vaccine during the most recent influenza season
Denominator
Children aged 2 to 4 years at the time of the interview. Only interviews conducted from March through August of the data year are included.
Comparable Healthy People 2010 Objective
Not applicable
Methodology Notes

This measure tracks the number of children aged 2 to 4 years who receive 1 dose influenza vaccine within the past influenza season.

The ACIP recommends two doses of influenza vaccine when needed for children 6 months to 8 years of age. NHIS, though, does not ask about more than one dose for children less than 9 years of age, nor does it ask about prior season vaccinations (this would be required to determine if two doses were indicated for the current season).

From the 2008 National Health Interview Survey: During the PAST 12 MONTHS, has (Sample child) had a flu shot? A flu shot is usually given in the fall and protects against influenza for the flu season

Revision History

Any change to the objective text, baseline, target, target-setting method or data source since the Healthy People 2020 launch.

Description of Changes Since the Healthy People 2020 Launch

In 2013, objectives IID-12.1 through 12.4 objectives were consolidated and revised to IID-12.11.

References

Additional resources about the objective.

  1. Klein, R.J.; Proctor, S.E.; Boudreault, M.A.; Turczyn, K.M. Healthy People 2010 Criteria for Data Suppression. Statistical Notes No. 24. Hyattsville, MD: National Center for Health Statistics. 2002.

About the Data

Description of the data source, numerator, denominator, survey questions, and other relevant details about the national estimate.

National Data Source
National Health Interview Survey (NHIS); Centers for Disease Control and Prevention, National Center for Health Statistics (CDC/NCHS)
Changed Since the Healthy People 2020 Launch
Yes
Measure
percent 
Baseline (Year)
25.8 (2008)
Target
80.0
Target-Setting Method
Maintain consistency with national programs, regulations, policies, and laws.
Numerator
Number of children aged 5 to 12 years who receive 1 dose influenza vaccine during the most recent influenza season
Denominator
Children aged 5 to 12 years at the time of the interview. Only interviews conducted from March through August of the data year are included.
Comparable Healthy People 2010 Objective
Not applicable
Methodology Notes

This measure tracks the number of children aged 5 to 12 years who receive 1 dose influenza vaccine within last flu season.

The ACIP recommends two doses of influenza vaccine when needed for children 6 months to 8 years of age. NHIS, though, does not ask about more than one dose for children less than 9 years of age, nor does it ask about prior season vaccinations (this would be required to determine if two doses were indicated for the current season).

Revision History

Any change to the objective text, baseline, target, target-setting method or data source since the Healthy People 2020 launch.

Description of Changes Since the Healthy People 2020 Launch

In 2013, objectives IID-12.1 through 12.4 objectives were consolidated and revised to IID-12.11.

References

Additional resources about the objective.

  1. Klein, R.J.; Proctor, S.E.; Boudreault, M.A.; Turczyn, K.M. Healthy People 2010 Criteria for Data Suppression. Statistical Notes No. 24. Hyattsville, MD: National Center for Health Statistics. 2002.

About the Data

Description of the data source, numerator, denominator, survey questions, and other relevant details about the national estimate.

National Data Source
National Health Interview Survey (NHIS); Centers for Disease Control and Prevention, National Center for Health Statistics (CDC/NCHS)
Changed Since the Healthy People 2020 Launch
Yes
Measure
percent 
Baseline (Year)
9.8 (2008)
Target
80.0
Target-Setting Method
Maintain consistency with national programs, regulations, policies, and laws.
Numerator
Number of persons aged 13 to 17 years reported to be vaccinated with influenza vaccine within the past flu season
Denominator
Number of persons aged 13 to 17 years at the time of the household interview
Comparable Healthy People 2010 Objective
Not applicable
Methodology Notes

In 2007 the Advisory Committee for Immunization Practices (ACIP) recommended that all children ages 6-59 months and their close contacts receive the influenza vaccine. Annual influenza vaccination was also recommended for persons with certain risk factors, health care personnel, and other persons in close contact with persons in groups at high risk. In 2008, the ACIP expanded its recommendation to include annual influenza vaccination of children aged 5-18 years beginning in the 2008-09 influenza season.

Revision History

Any change to the objective text, baseline, target, target-setting method or data source since the Healthy People 2020 launch.

Description of Changes Since the Healthy People 2020 Launch

In 2013, objectives IID-12.1 through 12.4 objectives were consolidated and revised to IID-12.11.

References

Additional resources about the objective.

  1. Klein, R.J.; Proctor, S.E.; Boudreault, M.A.; Turczyn, K.M. Healthy People 2010 Criteria for Data Suppression. Statistical Notes No. 24. Hyattsville, MD: National Center for Health Statistics. 2002.

About the Data

Description of the data source, numerator, denominator, survey questions, and other relevant details about the national estimate.

National Data Source
National Health Interview Survey (NHIS); Centers for Disease Control and Prevention, National Center for Health Statistics (CDC/NCHS)
Changed Since the Healthy People 2020 Launch
Yes
Measure
percent 
Baseline (Year)
24.9 (2008)
Target
80.0
Target-Setting Method
Maintain consistency with national programs, regulations, policies, and laws.
Numerator
Number of persons aged 18 to 64 years who report receiving an influenza vaccination during September through February of the survey year
Denominator
Number of persons aged 18 to 64 years. Only interviews conducted from March through August of the data year are included.
Comparable Healthy People 2010 Objective
Not applicable
Methodology Notes

From the 2008 National Health Interview Survey: [NUMERATOR:] During the PAST 12 MONTHS, have you had a flu shot? A flu shot is usually given in the fall and protects against influenza for the flu season. During what month and year did you receive your most recent flu shot?

Revision History

Any change to the objective text, baseline, target, target-setting method or data source since the Healthy People 2020 launch.

Description of Changes Since the Healthy People 2020 Launch

In 2013, objectives IID-12.5 through 12.8 objectives were consolidated and revised to IID-12.12.

References

Additional resources about the objective.

  1. Klein, R.J.; Proctor, S.E.; Boudreault, M.A.; Turczyn, K.M. Healthy People 2010 Criteria for Data Suppression. Statistical Notes No. 24. Hyattsville, MD: National Center for Health Statistics. 2002.

About the Data

Description of the data source, numerator, denominator, survey questions, and other relevant details about the national estimate.

National Data Source
National Health Interview Survey (NHIS); Centers for Disease Control and Prevention, National Center for Health Statistics (CDC/NCHS)
Changed Since the Healthy People 2020 Launch
Yes
Measure
percent 
Baseline (Year)
38.6 (2008)
Target
90.0
Target-Setting Method
Retention of Healthy People 2010 target
Numerator
Number of high-risk persons aged 18 to 64 years who report receiving an influenza vaccination during September through February
Denominator
Number of high-risk persons aged 18 to 64 years Only interviews conducted during March through August of the data are included
Comparable Healthy People 2010 Objective
Adapted from HP2010 objective
Methodology Notes

A high-risk person is defined as a respondent who answered "yes" to one or more of the conditions listed in the questions above. The only condition not included in the definition of high risk is skin cancer (see conditions 22 and 23 listed in the questions above). High-risk adults are defined by the Advisory Committee on Immunization Practices (ACIP).

Not all high-risk conditions for complications of influenza disease can be ascertained by NHIS (e.g., immunocompromised), and the sample size may be too small for some groups.

From the 2008 National Health Interview Survey: [NUMERATOR:] During the PAST 12 MONTHS, have you had a flu shot? A flu shot is usually given in the fall and protects against influenza for the flu season. During what month and year did you receive your most recent flu shot? [DENOMINATOR:] Have you EVER been told by a doctor or other health professional that you had... ... Coronary heart disease? ... Angina, also called angina pectoris? ... A heart attack (also called myocardial infarction)? ... Any kind of heart condition or heart disease (other than the ones I just asked about)? ... A stroke? ... Emphysema? ... Asthma? During the PAST 12 MONTHS, have you had an episode of asthma or asthma attack? Have you EVER been told by a doctor or other health professional that you had ... ... Cancer or a malignancy of any kind? [If yes:] What kind of cancer was it? (1) Bladder (2) Blood (3) Bone (4) Brain (5) Breast (6) Cervix (7) Colon (8) Esophagus (9) Gallbladder (10) Kidney (11) Larynx - windpipe (12) Leukemia (13) Liver (14) Lung (15) Lymphoma (16) Melanoma (17) Mouth/tongue/lip (18) Ovary (19) Pancreas (20) Prostate (21) Rectum (22) Skin (non-melanoma) (23) Skin (DK what kind) (24) Soft Tissue (muscle or fat) (25) Stomach (26) Testes (27) Throat - pharynx (28) Thyroid (29) Uterus (30) Other (96) More than 3 kinds (Other than during pregnancy,) Have you EVER been told by a doctor or health professional that you have diabetes or sugar diabetes? During the PAST 12 MONTHS, have you been told by a doctor or other health professional that you had.. ... Chronic bronchitis? ... Weak or failing kidneys? - Do not include kidney stones, bladder infections or incontinence. ... Any kind of liver condition?

Revision History

Any change to the objective text, baseline, target, target-setting method or data source since the Healthy People 2020 launch.

Description of Changes Since the Healthy People 2020 Launch

In 2013, objectives IID-12.5 through 12.8 objectives were consolidated and revised to IID-12.12.

References

Additional resources about the objective.

  1. Klein, R.J.; Proctor, S.E.; Boudreault, M.A.; Turczyn, K.M. Healthy People 2010 Criteria for Data Suppression. Statistical Notes No. 24. Hyattsville, MD: National Center for Health Statistics. 200

About the Data

Description of the data source, numerator, denominator, survey questions, and other relevant details about the national estimate.

National Data Source
National Health Interview Survey (NHIS); Centers for Disease Control and Prevention, National Center for Health Statistics (CDC/NCHS)
Changed Since the Healthy People 2020 Launch
Yes
Measure
percent 
Baseline (Year)
66.6 (2008)
Target
90.0
Target-Setting Method
Retention of Healthy People 2010 target
Numerator
Number of persons aged 65 years and older who report receiving an influenza vaccination during September through February of the survey year
Denominator
Number of persons aged 65 years and older. Only interviews conducted from March through August of the data year are included.
Comparable Healthy People 2010 Objective
Adapted from HP2010 objective
Methodology Notes

From the 2008 National Health Interview Survey: During the PAST 12 MONTHS, have you had a flu shot? A flu shot is usually given in the fall and protects against influenza for the flu season. During what month and year did you receive your most recent flu shot?

Revision History

Any change to the objective text, baseline, target, target-setting method or data source since the Healthy People 2020 launch.

Description of Changes Since the Healthy People 2020 Launch

In 2013, objectives IID-12.5 through 12.8 objectives were consolidated and revised to IID-12.12.

References

Additional resources about the objective.

  1. Klein, R.J.; Proctor, S.E.; Boudreault, M.A.; Turczyn, K.M. Healthy People 2010 Criteria for Data Suppression. Statistical Notes No. 24. Hyattsville, MD: National Center for Health Statistics. 2002.

About the Data

Description of the data source, numerator, denominator, survey questions, and other relevant details about the national estimate.

National Data Source
Minimum Data Set (MDS); Centers for Medicare & Medicaid Services (CMS)
Changed Since the Healthy People 2020 Launch
Yes
Measure
percent 
Baseline (Year)
62.3 (2005-2006)
Target
90.0
Target-Setting Method
Retention of Healthy People 2010 target
Numerator
Number of persons in long-term care facilities and nursing homes reported to have received an influenza vaccination during the influenza season
Denominator
Number of persons in nursing homes certified by the Centers for Medicare and Medicaid Services who had resident assessments conducted with a target date between October 1 and March 31
Comparable Healthy People 2010 Objective
Adapted from HP2010 objective
Methodology Notes

Data are from the population residing in long-term care facilities or nursing homes certified by the Centers for Medicare and Medicaid Services. This includes approximately 98% of all nursing home residents in the United States.

These data do not allow us to tell if a resident lived in multiple states. Thus, a resident will be included not more than once in a state, but may be included in more than one state. Past data show that only about 2-4 percent of residents lived in more than one state during the target period. A resident will be considered vaccinated if they were ever reported to be vaccinated with influenza at any assessment.

Vaccination status is ascertained for resident assessments conducted by the nursing facility staff.

Revision History

Any change to the objective text, baseline, target, target-setting method or data source since the Healthy People 2020 launch.

Description of Changes Since the Healthy People 2020 Launch

In 2013, objectives IID-12.5 through 12.8 objectives were consolidated and revised to IID-12.12.

References

Additional resources about the objective.

  1. Klein, R.J.; Proctor, S.E.; Boudreault, M.A.; Turczyn, K.M. Healthy People 2010 Criteria for Data Suppression. Statistical Notes No. 24. Hyattsville, MD: National Center for Health Statistics. 200

About the Data

Description of the data source, numerator, denominator, survey questions, and other relevant details about the national estimate.

National Data Source
National Health Interview Survey (NHIS); Centers for Disease Control and Prevention, National Center for Health Statistics (CDC/NCHS)
Changed Since the Healthy People 2020 Launch
Yes
Measure
percent 
Baseline (Year)
45.5 (2008)
Target
90.0
Target-Setting Method
Maintain consistency with national programs, regulations, policies, and laws.
Numerator
Number of health care personnel who potentially have contact with patients in the workplace (persons who report they currently volunteer or work in a hospital, medical clinic, doctor’s office, dentist’s office, nursing home or some other health care facility) who have received one or more doses of influenza vaccine during September through February
Denominator
Health care personnel who potentially have contact with patients in the workplace (persons who report they currently volunteer or work in a hospital, medical clinic, doctor’s office, dentist’s office, nursing home or some other health care facility) Only interviews conducted during March through August of the data year are included
Comparable Healthy People 2010 Objective
Adapted from HP2010 objective
Methodology Notes

Health care personnel are identified as persons reporting that they work in a health care facility.

From the 2008 National Health Interview Survey: [NUMERATOR:] During the PAST 12 MONTHS, have you had a flu shot? A flu shot is usually given in the fall and protects against influenza for the flu season. During what month and year did you receive your most recent flu shot? [DENOMINATOR:] Do you currently volunteer or work in a hospital, medical clinic, doctor’s office, dentist’s office, nursing home or some other health-care facility? This includes part-time and unpaid work in a health care facility as well as professional nursing care provided in the home. This includes non-health care professionals, such as administrative staff, who work in a health-care facility.

Revision History

Any change to the objective text, baseline, target, target-setting method or data source since the Healthy People 2020 launch.

Description of Changes Since the Healthy People 2020 Launch

In 2013, objective IID-12.9 was revised to IID-12.13.

References

Additional resources about the objective.

  1. Klein, R.J.; Proctor, S.E.; Boudreault, M.A.; Turczyn, K.M. Healthy People 2010 Criteria for Data Suppression. Statistical Notes No. 24. Hyattsville, MD: National Center for Health Statistics. 200

About the Data

Description of the data source, numerator, denominator, survey questions, and other relevant details about the national estimate.

National Data Source
National Health Interview Survey (NHIS); Centers for Disease Control and Prevention, National Center for Health Statistics (CDC/NCHS)
Changed Since the Healthy People 2020 Launch
Yes
Measure
percent 
Baseline (Year)
27.6 (2008)
Target
80.0
Target-Setting Method
Maintain consistency with national programs, regulations, policies, and laws.
Numerator
Number of pregnant women aged 18 to 44 years who report being pregnant at time of interview, and received an influenza vaccination from September through February
Denominator
Number of pregnant women aged 18 to 44 years who report being pregnant at time of interview, and who were interviewed from December of the first data year through April of the second data year
Comparable Healthy People 2010 Objective
Not applicable
Methodology Notes

The NHIS asks about current pregnancy status, so this measure will exclude some women who were pregnant during the September through February vaccination period (e.g., pregnant in December, delivered in February, and interviewed in April), and include some women who were not pregnant during the vaccination period (e.g., became pregnant in February and interviewed in April). Pregnant women interviewed during the vaccination period may have received an influenza vaccination while pregnant after the date of their interview. [NUMERATOR:] During the PAST 12 MONTHS, have you had a flu shot? A flu shot is usually given in the fall and protects against influenza for the flu season. During what month and year did you receive your most recent flu shot? [DENOMINATOR:] Are you currently pregnant?

From the 2008 National Health Interview Survey: NUMERATOR:] During the PAST 12 MONTHS, have you had a flu shot? A flu shot is usually given in the fall and protects against influenza for the flu season. During what month and year did you receive your most recent flu shot? [DENOMINATOR:] Are you currently pregnant?

Revision History

Any change to the objective text, baseline, target, target-setting method or data source since the Healthy People 2020 launch.

Description of Changes Since the Healthy People 2020 Launch

In 2013, objective IID-12.10 was revised to IID-12.14.

References

Additional resources about the objective.

  1. Klein, R.J.; Proctor, S.E.; Boudreault, M.A.; Turczyn, K.M. Healthy People 2010 Criteria for Data Suppression. Statistical Notes No. 24. Hyattsville, MD: National Center for Health Statistics. 200
IID-12 Increase the percentage of children and adults who are vaccinated annually against seasonal influenza

About the Data

Description of the data source, numerator, denominator, survey questions, and other relevant details about the national estimate.

National Data Source
National Health Interview Survey (NHIS); Centers for Disease Control and Prevention, National Center for Health Statistics (CDC/NCHS)
Changed Since the Healthy People 2020 Launch
Yes
Measure
percent 
Baseline (Year)
46.9 (2010-2011)
Target
70.0
Target-Setting Method
Maintain consistency with national programs, regulations, policies, and laws.
Numerator
Number of persons aged 6 months through 17 years reported to be vaccinated with at least one dose of influenza vaccine within the past influenza season
Denominator
Number of persons aged 6 months through 17 years as of November 1 of the influenza season
Questions Used to Obtain the National Baseline Data

From the 2010 National Health Interview Survey:

[NUMERATOR:]

DURING THE PAST 12 MONTHS, has [sample child] had a flu vaccination? This vaccine is usually given in the fall and protects against influenza for the flu season.

  1. Yes
  2. No

During what month and year did [sample child] receive his or her most recent flu vaccine?

  1. January
  2. February
  3. March
  4. April
  5. May
  6. June
  7. July
  8. August
  9. September
  10. October
  11. November
  12. December

Enter year of most recent flu vaccine.

Data Collection Frequency
Annual
Comparable Healthy People 2010 Objective
Adapted from HP2010 objective
Methodology Notes

In the 2010-2011 season, the Advisory Committee for Immunization Practices (ACIP) recommended that all persons aged 6 months and over receive the influenza vaccine. To better assess influenza vaccination coverage (1 or more doses) for each season, we reported coverage restricted to individuals interviewed during September through June, and vaccinated during August through May, using the Kaplan-Meier survival analysis procedure. Vaccination month was imputed when the child was reported to have been vaccinated but was missing the month and/or year of vaccination.

Changes Between HP2010 and HP2020
This objective differs from Healthy People 2010 objective 14-22h, which was intended to assess influenza vaccination of children aged 6 to 23 months. The objective was developmental during Healthy People 2010. It became measurable as of the Healthy People 2020 launch and was revised to include four Healthy People 2020 objectives: IID-12.1 (children aged 6 years to 23 months), IID-12.2 (children aged 2 to 4 years), IID-12.3 (children aged 5 to 12 years), and IID-12.4 (children aged 13 to 17 years).

Revision History

Any change to the objective text, baseline, target, target-setting method or data source since the Healthy People 2020 launch.

Description of Changes Since the Healthy People 2020 Launch

In 2014, objectives IID-12.1 through 12.4 assessing seasonal influenza vaccine coverage among children were consolidated into objective IID-12.11. The age groups of the individual objectives were combined to cover children aged 6 months through 17 years. The data source was changed from the National Immunization Survey to the National Health Interview Survey. The annual time period was revised from calendar year to influenza season.

About the Data

Description of the data source, numerator, denominator, survey questions, and other relevant details about the national estimate.

National Data Source
National Health Interview Survey (NHIS); Centers for Disease Control and Prevention, National Center for Health Statistics (CDC/NCHS)
Changed Since the Healthy People 2020 Launch
Yes
Measure
percent 
Baseline (Year)
38.1 (2010-2011)
Target
70.0
Target-Setting Method
Maintain consistency with national programs, regulations, policies, and laws.
Numerator
Number of persons aged 18 years and over reported to be vaccinated with influenza vaccine within the past influenza season
Denominator
Number of persons aged 18 years and over at the time of the household interview
Questions Used to Obtain the National Baseline Data

From the 2010 National Health Interview Survey:

[NUMERATOR:]

DURING THE PAST 12 MONTHS, have you had a flu shot? A flu shot is usually given in the fall and protects against influenza for the flu season.

  1. Yes
  2. No

During what month and year did you receive your most recent flu shot?

  1. January
  2. February
  3. March
  4. April
  5. May
  6. June
  7. July
  8. August
  9. September
  10. October
  11. November
  12. December

Enter year of most recent flu vaccine.

DURING THE PAST 12 MONTHS, have you had a flu vaccine sprayed in your nose by a doctor or other health professional? A health professional may have let you spray it. This vaccine is usually given in the fall and protects against influenza for the flu season.

  1. Yes
  2. No

During what month and year did you receive your most recent flu nasal spray?

  1. January
  2. February
  3. March
  4. April
  5. May
  6. June
  7. July
  8. August
  9. September
  10. October
  11. November
  12. December

Enter year of most recent flu nasal spray.

Data Collection Frequency
Annual
Comparable Healthy People 2010 Objective
Adapted from HP2010 objective
Methodology Notes

In the 2010-11 season, the Advisory Committee for Immunization Practices (ACIP) recommended that all persons aged 6 months and over receive the influenza vaccine. To better assess influenza vaccination coverage for each season, we reported coverage restricted to individuals interviewed during September through June, and vaccinated during August through May, using the Kaplan-Meier survival analysis procedure. Vaccination month was imputed when the adult was reported to have been vaccinated but was missing the month and/or year of vaccination.

Changes Between HP2010 and HP2020
This objective differs from Healthy People 2010 objectives 14-29a, 14-29c, and 14-29e, which tracked influenza vaccination coverage in noninstitutionalized persons aged 65 and over (14-29a), high risk noninstitutionalized persons aged 18 to 64 years (14-29c) and institutionalized persons (14-29e). These Healthy People 2010 objectives were revised to include 4 Healthy People 2020 objectives which tracked influenza vaccination coverage among noninstitutionalized persons aged 18 to 64 years (IID-12.5), noninstitutionalized high-risk persons aged 18 to 64 years (IID-12.6), noninstitutionalized persons aged 65 years and over (IID-12.8), and institutionalized persons (IID-12.8).

Revision History

Any change to the objective text, baseline, target, target-setting method or data source since the Healthy People 2020 launch.

Description of Changes Since the Healthy People 2020 Launch

In 2014, objectives IID-12.5 through 12.8, assessing seasonal influenza vaccination coverage among adults were consolidated into objective IID-12.12. The age and risk groups of the individual objectives were combined to cover all persons aged 18 years and over. The annual time period was revised from calendar year to influenza season.

About the Data

Description of the data source, numerator, denominator, survey questions, and other relevant details about the national estimate.

National Data Source
National Health Interview Survey (NHIS); Centers for Disease Control and Prevention, National Center for Health Statistics (CDC/NCHS)
Changed Since the Healthy People 2020 Launch
Yes
Measure
percent 
Baseline (Year)
55.8 (2010-2011)
Target
90.0
Target-Setting Method
Maintain consistency with national programs, regulations, policies, and laws.
Numerator
Number of healthcare personnel aged 18 years and over reporting they have had influenza vaccination in the past season
Denominator
Number of healthcare personnel aged 18 years and over at the time of the household interview
Questions Used to Obtain the National Baseline Data

From the 2010 National Health Interview Survey:

[NUMERATOR:]

DURING THE PAST 12 MONTHS, have you had a flu shot? A flu shot is usually given in the fall and protects against influenza for the flu season.

  1. Yes
  2. No

During what month and year did you receive your most recent flu shot?

  1. January
  2. February
  3. March
  4. April
  5. May
  6. June
  7. July
  8. August
  9. September
  10. October
  11. November
  12. December

Enter year of most recent flu vaccine.

DURING THE PAST 12 MONTHS, have you had a flu vaccine sprayed in your nose by a doctor or other health professional? A health professional may have let you spray it. This vaccine is usually given in the fall and protects against influenza for the flu season.

  1. Yes
  2. No

During what month and year did you receive your most recent flu nasal spray?

  1. January
  2. February
  3. March
  4. April
  5. May
  6. June
  7. July
  8. August
  9. September
  10. October
  11. November
  12. December

Enter year of most recent flu nasal spray.

[DENOMINATOR:]

Do you currently volunteer or work in a hospital, medical clinic, doctor’s office, dentist’s office, nursing home or some other health-care facility? This includes part-time and unpaid work in a health care facility as well as professional nursing care provided in the home.

  1. Yes
  2. No
Data Collection Frequency
Annual
Comparable Healthy People 2010 Objective
Adapted from HP2010 objective
Methodology Notes

The Advisory Committee for Immunization Practices (ACIP) recommends that all persons aged 6 months and over receive the influenza vaccine, with continued emphasis placed on vaccination of persons who live with or care for persons at higher risk for influenza-related complications, including health-care personnel. Annual influenza vaccination is recommended for all health-care personnel and persons in training for health-care professions. Personnel in health-care settings who should be vaccinated include physicians, nurses, and other workers in inpatient and outpatient-care settings, medical emergency-response workers (e.g., paramedics and emergency medical technicians), employees of nursing home and long-term care facilities who have contact with patients or residents, and students in these professions who will have contact with patients.

Based on the National Health Interview Survey (NHIS), health-care personnel are defined as persons aged 18 years and over who reported that they currently volunteer or work in a hospital, medical clinic, doctor’s office, dentist’s office, nursing home or some other health-care facility, including part-time and unpaid work in a health care facility as well as professional nursing care provided in the home.

To better assess influenza vaccination coverage for each season, we reported coverage restricted to individuals interviewed during September through June, and vaccinated during August through May, using the Kaplan-Meier survival analysis procedure. Vaccination month was imputed when the adult was reported to have been vaccinated but was missing the month and/or year of vaccination.

Changes Between HP2010 and HP2020
This objective differs from Healthy People 2010 objective 14-29g, which tracked the influenza vaccination coverage among health care workers aged 18 to 64 years. Objective 14-29g was adapted to Healthy People 2020 objective IID-12.9, which tracked influenza vaccination coverage among health care workers aged 18 years and over.

Revision History

Any change to the objective text, baseline, target, target-setting method or data source since the Healthy People 2020 launch.

Description of Changes Since the Healthy People 2020 Launch

In 2014, objective IID-12.9 was revised to objective IID-12.13. The annual time period was revised from calendar year to influenza season.

About the Data

Description of the data source, numerator, denominator, survey questions, and other relevant details about the national estimate.

National Data Source
Pregnancy Risk Assessment Monitoring System (PRAMS); Centers for Disease Control and Prevention, National Center for Chronic Disease Prevention and Health Promotion (CDC/NCCDPHP)
Changed Since the Healthy People 2020 Launch
Yes
Measure
percent 
Numerator
***

Revision History

Any change to the objective text, baseline, target, target-setting method or data source since the Healthy People 2020 launch.

Description of Changes Since the Healthy People 2020 Launch

In 2014, Objective IID-12.10 was revised to objective IID-12.14 and the objective reverted to developmental status. The (proposed) data source was changed from the National Health Interview Survey to the Pregnancy Risk Assessment Monitoring System.

IID-13 Increase the percentage of adults who are vaccinated against pneumococcal disease

About the Data

Description of the data source, numerator, denominator, survey questions, and other relevant details about the national estimate.

National Data Source
National Health Interview Survey (NHIS); Centers for Disease Control and Prevention, National Center for Health Statistics (CDC/NCHS)
Changed Since the Healthy People 2020 Launch
No
Measure
percent 
Baseline (Year)
60.1 (2008)
Target
90.0
Target-Setting Method
Maintain consistency with national programs, regulations, policies, and laws.
Numerator
Number of persons aged 65 years and older who report ever receiving a pneumococcal vaccination
Denominator
Number of persons aged 65 years and older
Questions Used to Obtain the National Baseline Data

From the 2009 National Health Interview Survey: Have you EVER had a pneumonia vaccination? This shot is usually given only once in a person's lifetime and is different from the flu shot.

Data Collection Frequency
Annual
Comparable Healthy People 2010 Objective
Retained from HP2010 objective

References

Additional resources about the objective.

  1. Klein, R.J.; Proctor, S.E.; Boudreault, M.A.; Turczyn, K.M. Healthy People 2010 Criteria for Data Suppression. Statistical Notes No. 24. Hyattsville, MD: National Center for Health Statistics. 2002.

About the Data

Description of the data source, numerator, denominator, survey questions, and other relevant details about the national estimate.

National Data Source
National Health Interview Survey (NHIS); Centers for Disease Control and Prevention, National Center for Health Statistics (CDC/NCHS)
Changed Since the Healthy People 2020 Launch
No
Measure
percent 
Baseline (Year)
16.6 (2008)
Target
60.0
Target-Setting Method
Maintain consistency with national programs, regulations, policies, and laws.
Numerator
Number of high-risk persons aged 18 to 64 years who report ever receiving a pneumococcal vaccination
Denominator
Number of high-risk persons aged 18 to 64 years
Questions Used to Obtain the National Baseline Data

From the 2009 National Health Interview Survey:

[NUMERATOR:]

Have you EVER had a pneumonia vaccination? This shot is usually given only once in a person's lifetime and is different from the flu shot.

[DENOMINATOR:]

Have you EVER been told by a doctor or other health professional that you had…
… Coronary heart disease?
… Angina, also called angina pectoris?
… A heart attack (also called myocardial infarction)?
… Any kind of heart condition or heart disease (other than the ones I just asked about)?
… Emphysema?
… Asthma?

During the PAST 12 MONTHS, have you had an episode of asthma or asthma attack?

Have you EVER been told by a doctor or other health professional that you had …
… Cancer or a malignancy of any kind?

[If yes:] What kind of cancer was it?
(1) Bladder
(2) Blood
(3) Bone
(4) Brain
(5) Breast
(6) Cervix
(7) Colon
(8) Esophagus
(9) Gallbladder
(10) Kidney
(11) Larynx - windpipe
(12) Leukemia
(13) Liver
(14) Lung
(15) Lymphoma
(16) Melanoma
(17) Mouth/tongue/lip
(18) Ovary
(19) Pancreas
(20) Prostate
(21) Rectum
(22) Skin (non-melanoma)
(23) Skin (DK what kind)
(24) Soft Tissue (muscle or fat)
(25) Stomach
(26) Testes
(27) Throat - pharynx
(28) Thyroid
(29) Uterus
(30) Other
(96) More than 3 kinds

(Other than during pregnancy,) Have you EVER been told by a doctor or health professional that you have diabetes or sugar diabetes?

During the PAST 12 MONTHS, have you been told by a doctor or other health professional that you had..
… chronic bronchitis?
… Weak or failing kidneys? - Do not include kidney stones, bladder infections or incontinence.
… Any kind of liver condition?

Current smokers?

Data Collection Frequency
Annual
Comparable Healthy People 2010 Objective
Retained from HP2010 objective
Methodology Notes

A high-risk person is defined as a respondent who answered "yes" to one or more of the conditions listed in the questions on the NHIS. The only condition not included in the definition of high risk is skin cancer (see conditions 22 and 23 listed in the questions above). High-risk adults are defined by the Advisory Committee on Immunization Practices (ACIP).

Not all high-risk conditions for complications of pneumococcal disease can be ascertained by NHIS (e.g., immunocompromised), and the sample size may be too small for some groups.

References

Additional resources about the objective.

  1. Klein, R.J.; Proctor, S.E.; Boudreault, M.A.; Turczyn, K.M. Healthy People 2010 Criteria for Data Suppression. Statistical Notes No. 24. Hyattsville, MD: National Center for Health Statistics. 200

About the Data

Description of the data source, numerator, denominator, survey questions, and other relevant details about the national estimate.

National Data Source
Minimum Data Set (MDS); Centers for Medicare & Medicaid Services (CMS)
Changed Since the Healthy People 2020 Launch
No
Measure
percent 
Baseline (Year)
66.4 (2005-2006)
Target
90.0
Target-Setting Method
Maintain consistency with national programs, regulations, policies, and laws.
Numerator
Number of persons in long-term care facilities and nursing homes certified by the Centers for Medicare and Medicaid Services (CMS) reported to have up to date pneumococcal vaccination
Denominator
Number of persons in long-term care facilities and nursing homes certified by the Centers for Medicare and Medicaid Services (CMS). Residents who lived in multiple states were included once in each state. Residents who lived in multiple homes within a state were only included in that state once.
Data Collection Frequency
Periodic
Comparable Healthy People 2010 Objective
Adapted from HP2010 objective
Methodology Notes

Data include residents of CMS-certified nursing homes who ever had an assessment (in the MDS dataset). Percentage includes U.S. residents (i.e., not adjusted for state or facility). Residents who lived in multiple states during a single year were included once in each state they lived in.

Vaccination status is ascertained by the staff member completing the resident assessment instrument based on medical records.

Caveats and Limitations
These data do not allow us to tell if a resident lived in multiple states. Thus, a resident will be included not more than once in a state, but may be included in more than one state. Past data show that only about 2-4 percent of residents lived in more than one state during the target period. A resident will be considered vaccinated if they were ever reported to be vaccinated with PPV at any assessment.

References

Additional resources about the objective.

  1. Klein, R.J.; Proctor, S.E.; Boudreault, M.A.; Turczyn, K.M. Healthy People 2010 Criteria for Data Suppression. Statistical Notes No. 24. Hyattsville, MD: National Center for Health Statistics. 2002.

About the Data

Description of the data source, numerator, denominator, survey questions, and other relevant details about the national estimate.

National Data Source
National Health Interview Survey (NHIS); Centers for Disease Control and Prevention, National Center for Health Statistics (CDC/NCHS)
Changed Since the Healthy People 2020 Launch
No
Measure
percent 
Baseline (Year)
6.7 (2008)
Target
30.0
Target-Setting Method
Maintain consistency with national programs, regulations, policies, and laws.
Numerator
Number of persons aged 60 years and older who report having ever received zoster vaccine (shingles vaccine)
Denominator
Number of persons aged 60 years and older
Questions Used to Obtain the National Baseline Data

From the 2009 National Health Interview Survey: Shingles is an outbreak of a rash or blisters on the skin that may be associated with severe pain. The pain is generally on one side of the body or face. Shingles is caused by the chicken pox virus. A vaccine for shingles has been available since May 2006. Have you ever had the Zoster (ZOSS-ter) or Shingles vaccine, also called Zostavax®?

Data Collection Frequency
Annual
Comparable Healthy People 2010 Objective
Not applicable

References

Additional resources about the objective.

  1. Klein, R.J.; Proctor, S.E.; Boudreault, M.A.; Turczyn, K.M. Healthy People 2010 Criteria for Data Suppression. Statistical Notes No. 24. Hyattsville, MD: National Center for Health Statistics. 2002.
IID-15 (Developmental) Increase hepatitis B vaccine coverage among high-risk populations

About the Data

Description of the data source, numerator, denominator, survey questions, and other relevant details about the national estimate.

National Data Source
Changed Since the Healthy People 2020 Launch
No
Measure
*** Missing *** 
Numerator
*** Missing ***
Comparable Healthy People 2010 Objective
Adapted from HP2010 objective

About the Data

Description of the data source, numerator, denominator, survey questions, and other relevant details about the national estimate.

National Data Source
National Notifiable Diseases Surveillance System (NNDSS); Centers for Disease Control and Prevention, Public Health Surveillance and Informatics Program Office (CDC/PHSIPO)
Changed Since the Healthy People 2020 Launch
No
Measure
*** Missing *** 
Numerator
Number of reported (in the past 12 months) symptomatic hepatitis B cases among males that indicated homosexual or bisexual preference who report ever receiving hepatitis B vaccine
Denominator
Number of men who report homosexual or bisexual preference
Comparable Healthy People 2010 Objective
Adapted from HP2010 objective

References

Additional resources about the objective.

  1. http://www.cdc.gov/mmwr/preview/mmwrhtml/rr5516a1.htm
  2. Centers for Disease Control and Prevention. A Comprehensive Immunization Strategy to Eliminate Transmission of Hepatitis B Virus Infection in the United States: Recommendations of the Advisory Committee on Immunization Practices (ACIP) Part II: Immunization of Adults. MMWR December 8, 2006;55(No. RR-16): 1-33.
  3. Gallagher K, Sullivan P, Lansky A, Onorato I. Behavioral Surveillance Among People at Risk for HIV Infection in the U.S.: The National HIV Behavioral Surveillance System. Public Health Reports Volume 122/ Supplement (1): 32-38. http://www.publichealthreports.org/archives/issueopen.cfm?articleID=1801

About the Data

Description of the data source, numerator, denominator, survey questions, and other relevant details about the national estimate.

National Data Source
National Health Interview Survey (NHIS); Centers for Disease Control and Prevention, National Center for Health Statistics (CDC/NCHS)
Changed Since the Healthy People 2020 Launch
No
Measure
percent 
Baseline (Year)
64.3 (2008)
Target
90.0
Target-Setting Method
Maintain consistency with national programs, regulations, policies, and laws.
Numerator
Number of health care workers reporting they have had at least three doses of hepatitis B vaccine
Denominator
Number of employed health care workers
Questions Used to Obtain the National Baseline Data

Health care personnel who have had at least three doses of hepatitis B vaccine were identified as those who responded to the following questions.

• Have you EVER received the hepatitis B vaccine?
• Did you receive at least 3 doses of the hepatitis B vaccine, or less than 3 doses?

Data Collection Frequency
Periodic
Comparable Healthy People 2010 Objective
Retained from HP2010 objective
Methodology Notes

Number of health care personnel who potentially have contact with patients in the workplace (persons who report they currently volunteer or work in a hospital, medical clinic, doctor’s office, dentist’s office, nursing home or some other health care facility) who have received one or more doses of influenza vaccine during September through February.]

References

Additional resources about the objective.

  1. Agerton, T.B.; Mahoney, F.J.; Polish, L.B.; et al. Impact of the bloodborne pathogens standard on vaccination of healthcare workers with hepatitis B vaccine. Infection Control and Hospital Epidemiology 16: 287-291, 1995.
  2. Mahoney, F.J.; Stewart, K.; Hu, H.; et al. Progress toward the elimination of hepatitis B virus transmission among health care workers in the United States. Archives of Internal Medicine 157: 2601-2605, 1997.

About the Data

Description of the data source, numerator, denominator, survey questions, and other relevant details about the national estimate.

National Data Source
National Notifiable Diseases Surveillance System (NNDSS); Centers for Disease Control and Prevention, Public Health Surveillance and Informatics Program Office (CDC/PHSIPO)
Changed Since the Healthy People 2020 Launch
No
Measure
*** Missing *** 
Numerator
Number of reported symptomatic hepatitis B cases (in the last 12 months) among males that indicated homosexual or bisexual preference who report injecting drugs (in the last 12 months?) who ever received hepatitis B vaccine
Denominator
Number of men who report homosexual or bisexual preference who report injecting drugs (in the last 12 months?)
Comparable Healthy People 2010 Objective
Not applicable

References

Additional resources about the objective.

  1. Centers for Disease Control and Prevention. A Comprehensive Immunization Strategy to Eliminate Transmission of Hepatitis B Virus Infection in the United States
  2. Gallagher K, Sullivan P, Lansky A, Onorato I. Behavioral Surveillance Among People at Risk for HIV Infection in the U.S.: The National HIV Behavioral Surveillance System. Public Health Reports Volume 122/ Supplement (1): 32-38. http://www.publichealthreports.org/archives/issueopen.cfm?articleID=1801
  3. Recommendations of the Advisory Committee on Immunization Practices (ACIP) Part II: Immunization of Adults. MMWR December 8, 2006;55(No. RR-16): 1-33.

About the Data

Description of the data source, numerator, denominator, survey questions, and other relevant details about the national estimate.

National Data Source
Vaccine Adverse Event Reporting System (VAERS); Centers for Disease Control and Prevention and Food and Drug Administration (CDC and FDA)
Changed Since the Healthy People 2020 Launch
No
Measure
*** Missing *** 
Numerator
*** Missing ***
Comparable Healthy People 2010 Objective
Retained from HP2010 objective
IID-17 Increase the percentage of providers who have had vaccination coverage levels among children in their practice population measured within the past year

About the Data

Description of the data source, numerator, denominator, survey questions, and other relevant details about the national estimate.

National Data Source
Program Annual Progress Assessments (PAPA); Centers for Disease Control and Prevention, National Center for Immunization and Respiratory Diseases (CDC/NCIRD)
Changed Since the Healthy People 2020 Launch
Yes
Measure
percent 
Baseline (Year)
40.0 (2009)
Target
50.0
Target-Setting Method
Maintain consistency with national programs, regulations, policies, and laws.
Numerator
Number of public provider sites that routinely provided immunizations in the past year to children 6 years and younger and participated in a provider assessment at least once in the past year
Denominator
Number of public provider sites that routinely provided immunizations in the past year to children 6 years and younger
Data Collection Frequency
Annual
Comparable Healthy People 2010 Objective
Retained from HP2010 objective
Methodology Notes

Data are the percent of Vaccines for Children (VFC) enrolled providers that had assessments of their immunization coverage rates as part of the Assessment, Feedback, Incentives, and eXchange (AFIX) process.

A provider site is a service delivery location that maintains permanent records, excluding temporary locations or mobile immunization clinics or fairs and the like. Well-child clinics and immunization-only clinics in the same location were counted as separate sites only if they maintain separate sets of records.

Public providers include health department clinics, community/migrant health centers, Indian Health Service/Tribal health clinics, or other public providers (e.g., any other public clinic that provides immunizations, such as a county medical center outpatient clinic).

Private providers are individual or group primary care or pediatric practices and may include providers for which some or all of their clients are members of different managed care plans or managed care organizations. A public provider assessment is an assessment that includes a review of a random sample (or 100 percent) of immunization records. The assessment may have been conducted by project, clinic, or contractual personnel. A private provider assessment is an assessment that includes a review of immunization records either through a manual sample or through the use of an immunization registry. The assessment may have been conducted either by immunization project staff, through a contractual agreement that provides this service, or by the provider itself, in cooperation with the immunization project staff.

Revision History

Any change to the objective text, baseline, target, target-setting method or data source since the Healthy People 2020 launch.

Description of Changes Since the Healthy People 2020 Launch

The data source changed from Annual Immunization Assessment Reports, CDC, NCIRD to Program Annual Progress Assessments, CDC, NCIRD. Program Annual Progress Assessments is a more accurate data source for this objective. The Annual Immunization Assessment Reports (former data source) is only one part of the Program Annual Progress Assessments. The former data source cannot be found using search engines; the updated data source is more user-friendly for all HP2020 stakeholders and the public audience.

About the Data

Description of the data source, numerator, denominator, survey questions, and other relevant details about the national estimate.

National Data Source
Program Annual Progress Assessments (PAPA); Centers for Disease Control and Prevention, National Center for Immunization and Respiratory Diseases (CDC/NCIRD)
Changed Since the Healthy People 2020 Launch
Yes
Measure
percent 
Baseline (Year)
33.0 (2009)
Target
50.0
Target-Setting Method
Maintain consistency with national programs, regulations, policies, and laws.
Numerator
Number of private provider sites that routinely provided immunizations in the past year to children 6 years and younger and participated in a provider assessment at least once in the past year
Denominator
Number of private provider sites that routinely provided immunizations in the past year to children 6 years and younger
Data Collection Frequency
Annual
Comparable Healthy People 2010 Objective
Retained from HP2010 objective
Methodology Notes

Data are the percent of Vaccines for Children (VFC) enrolled providers that had assessments of their immunization coverage rates as part of the Assessment, Feedback, Incentives, and eXchange (AFIX) process.

A provider site is a service delivery location that maintains permanent records, excluding temporary locations or mobile immunization clinics or fairs and the like. Well-child clinics and immunization-only clinics in the same location were counted as separate sites only if they maintain separate sets of records.

Public providers include health department clinics, community/migrant health centers, Indian Health Service/Tribal health clinics, or other public providers (e.g., any other public clinic that provides immunizations, such as a county medical center outpatient clinic).

Private providers are individual or group primary care or pediatric practices and may include providers for which some or all of their clients are members of different managed care plans or managed care organizations. A public provider assessment is an assessment that includes a review of a random sample (or 100 percent) of immunization records. The assessment may have been conducted by project, clinic, or contractual personnel. A private provider assessment is an assessment that includes a review of immunization records either through a manual sample or through the use of an immunization registry. The assessment may have been conducted either by immunization project staff, through a contractual agreement that provides this service, or by the provider itself, in cooperation with the immunization project staff.

Revision History

Any change to the objective text, baseline, target, target-setting method or data source since the Healthy People 2020 launch.

Description of Changes Since the Healthy People 2020 Launch

The data source changed from Annual Immunization Assessment Reports, CDC, NCIRD to Program Annual Progress Assessments, CDC, NCIRD. Program Annual Progress Assessments is a more accurate data source for this objective. The Annual Immunization Assessment Reports (former data source) is only one part of the Program Annual Progress Assessments. The former data source cannot be found using search engines; the updated data source is more user-friendly for all HP2020 stakeholders and the public audience.

About the Data

Description of the data source, numerator, denominator, survey questions, and other relevant details about the national estimate.

National Data Source
Immunization Information Systems Annual Report (IISAR); Centers for Disease Control and Prevention, National Center for Immunization and Respiratory Diseases (CDC/NCIRD)
Changed Since the Healthy People 2020 Launch
No
Measure
percent 
Baseline (Year)
75.0 (2008)
Target
95.0
Target-Setting Method
Projection/trend analysis
Numerator
Number of children under 6 years of age with two or more immunizations recorded in the immunization information system
Denominator
Number of children under 6 years of age (U.S. Census)
Data Collection Frequency
Annual
Comparable Healthy People 2010 Objective
Retained from HP2010 objective

About the Data

Description of the data source, numerator, denominator, survey questions, and other relevant details about the national estimate.

National Data Source
Annual School Assessment Reports; Centers for Disease Control and Prevention, National Center for Immunization and Respiratory Diseases (CDC/NCIRD)
Changed Since the Healthy People 2020 Launch
Yes
Measure
number 
Baseline (Year)
11 (2009-2010)
Target
51
Target-Setting Method
Maintain consistency with national programs, regulations, policies, and laws.
Numerator
Number of states (including the District of Columbia) who collect kindergarten vaccination coverage data according to CDC minimum standards
Denominator
Number of states (including the District of Columbia)
Data Collection Frequency
Annual
Comparable Healthy People 2010 Objective
Not applicable
Methodology Notes

This measure is designed to encourage states to follow standard procedures and methodology that will result in quality data.

The states are asked to use comparable methods to allow comparison and to ensure that the information collected is accurate. The methodology must include these standards: (1) Meeting all age-appropriate ACIP recommendations , including 2 doses of varicella, (2) Appropriate sampling methodology, (3) Validation of data collected, (4) Data collection by trained personnel, (5) Data on vaccination history from a provider, and (6) Data collected by appropriate date (December 31 of each year).

Caveats and Limitations
Sampling methodology varies by state for kindergarten vaccination status, which is a major limitation (e.g., some states selected a random sample of kindergarten children and others conducted a census of all kindergarten children).

Revision History

Any change to the objective text, baseline, target, target-setting method or data source since the Healthy People 2020 launch.

Description of Changes Since the Healthy People 2020 Launch

The baseline estimate and year were revised from 13 (2009) to 11 (2009-10) because reliable data were not available before the 2009-10 school year. The target was not revised.

About the Data

Description of the data source, numerator, denominator, survey questions, and other relevant details about the national estimate.

National Data Source
Immunization Information Systems Annual Report (IISAR); Centers for Disease Control and Prevention, National Center for Immunization and Respiratory Diseases (CDC/NCIRD)
Changed Since the Healthy People 2020 Launch
No
Measure
number 
Baseline (Year)
14 (2009)
Target
40
Target-Setting Method
Maintain consistency with national programs, regulations, policies, and laws.
Numerator
Number of States that have 80% of adolescents (11-18 years old) with 2 or more age-appropriate immunizations recorded in their immunization information system
Denominator
50 States plus District of Columbia
Data Collection Frequency
Annual
Comparable Healthy People 2010 Objective
Not applicable
Methodology Notes

Approximately 88 percent of CDC immunization information systems grantees (states) have lifespan systems, and a number of vaccines have recently been recommended for routine use among adolescents (e.g., Tdap, MCV, HPV).

Count all doses (valid and invalid) for adolescents 11-18 years old. Count vaccine doses that are ACIP recommended for 11-18 year olds

About the Data

Description of the data source, numerator, denominator, survey questions, and other relevant details about the national estimate.

National Data Source
Rabies Surveillance Network (RSN); Centers for Disease Control and Prevention, National Center for Emerging and Zoonotic Infectious Diseases (CDC/NCEZID)
Changed Since the Healthy People 2020 Launch
No
Measure
number 
Baseline (Year)
8 (2010)
Target
52
Target-Setting Method
Projection/trend analysis
Numerator
Number of state public health laboratories (total 52 including the District of Columbia, Puerto Rico, and New York City, and excluding Hawaii) sending weekly data uploads to the RabID system
Data Collection Frequency
Periodic
Comparable Healthy People 2010 Objective
Not applicable
Methodology Notes

RabID is enhanced surveillance via a new comprehensive GIS-based real-time system that provides essential information on rabies occurrence for states and partnering organizations needed for timely prevention and control and has integrated data sharing among local, state, and federal agencies for strategic responses to outbreaks.

Data are collected routinely through the Public Health Laboratory Information System (PHLIS) or at the end of year when data is sent directly from states that have not implemented electronic messaging.

About the Data

Description of the data source, numerator, denominator, survey questions, and other relevant details about the national estimate.

National Data Source
State Public Health Laboratories Performing Antiviral Resistance Testing; Centers for Disease Control and Prevention, National Center for Immunization and Respiratory Diseases (CDC/NCIRD)
Changed Since the Healthy People 2020 Launch
No
Measure
number 
Baseline (Year)
3 (2009)
Target
25
Target-Setting Method
Maintain consistency with national programs, regulations, policies, and laws.
Numerator
Number of state public health laboratories who have submitted reports to CDC listing virus susceptibility to either class of antiviral drug (adamantanes or neuraminidase inhibitors)
Data Collection Frequency
Annual
Comparable Healthy People 2010 Objective
Not applicable
Methodology Notes

Antivirals are the only prescribed medication available to treat a patient once they have contracted influenza. Monitoring for viruses resistant to antivirals is key to inform prescription and other non-pharmaceutical and pharmaceutical intervention guidance. In 2009, CDC has been the only public health laboratory conducting a comprehensive monitoring of influenza A and B virus susceptibilities to four licensed anti-influenza drugs in the United States.

About the Data

Description of the data source, numerator, denominator, survey questions, and other relevant details about the national estimate.

National Data Source
National Notifiable Diseases Surveillance System (NNDSS); Centers for Disease Control and Prevention, Public Health Surveillance and Informatics Program Office (CDC/PHSIPO)
Changed Since the Healthy People 2020 Launch
No
Measure
per 100,000 
Baseline (Year)
1.0 (2007)
Target
0.3
Target-Setting Method
Projection/trend analysis
Numerator
Number of new symptomatic hepatitis A cases reported in the past 12 months
Denominator
Total population in reporting states
Data Collection Frequency
Annual
Comparable Healthy People 2010 Objective
Retained from HP2010 objective
Methodology Notes

A case definition for new symptomatic cases of hepatitis A is available from CDC.

To obtain state-specific measures for this measure, local Viral Hepatitis Surveillance Program data are used to determine the number of symptomatic hepatitis A cases occurring in the State in the past 12 months.

References

Additional resources about the objective.

  1. CDC. Prevention of hepatitis A through active or passive immunization: recommendations of the Advisory Committee on Immunization Practices (ACIP). MMWR 2006;55 (No. RR-7). http://www.cdc.gov/mmwr/preview/mmwrhtml/rr5507a1.htm.
  2. Centers for Disease Control and Prevention (CDC). Case definitions for infectious conditions under public health surveillance. http://www.cdc.gov/osels/ph_surveillance/nndss/casedef/hepatitisacurrent.htm
  3. Daniels D, Grytdal S, Wasley A. Surveillance for acute viral hepatitis - United States, 2007. MMWR Surveillance Summary. May 22 2009;58(3):1-27. http://www.cdc.gov/mmwr/PDF/ss/ss5803.pdf

About the Data

Description of the data source, numerator, denominator, survey questions, and other relevant details about the national estimate.

National Data Source
National Vital Statistics System-Natality (NVSS-N); Centers for Disease Control and Prevention, National Center for Health Statistics (CDC/NCHS)
Perinatal Hepatitis B Prevention Program (PHBPP); Centers for Disease Control and Prevention, National Center for HIV/AIDS, Viral Hepatitis, STD, and TB Prevention (CDC/NCHHSTP)
Changed Since the Healthy People 2020 Launch
No
Measure
number 
Baseline (Year)
799 (2007)
Target
400
Target-Setting Method
Maintain consistency with national programs, regulations, policies, and laws.
Numerator
Number of estimated chronic hepatitis B virus (HBV) infections occurring among infants and children aged 1-24 months of HBV-infected mothers
Data Collection Frequency
Annual
Comparable Healthy People 2010 Objective
Retained from HP2010 objective
Methodology Notes

The estimated number of births to HBV-infected mothers is derived by applying race- and ethnicity- specific estimates of the prevalence of hepatitis B surface antigen to NVSS-N annual natality data.

Using data collected by the Perinatal Hepatitis B Prevention Program and NVSS-N, this measure is based on the following estimation procedure:

Multiply the total births per year to HBsAg- positive women by the proportion of pregnant women screened for HBsAg and then by the proportion of infants born to identified HBsAg- positive women who receive the vaccine (this estimates the number of infants who were born to identified HBsAg-positive women and received at least one dose of vaccine). Multiply the total number of infants who were born to HBsAg-positive women and received at least one dose of vaccine by the proportion of vaccinated infants who will remain susceptible, and add to the number of infants born to HBsAg-positive women who are not vaccinated (this estimates the number of infants born to HBsAg-positive women who remain susceptible). Finally, multiply number of infants born to HBsAg- positive women remaining susceptible by the proportion of susceptible infants who will become infected and then by the proportion of infected infants who will remain chronically infected with HBV.

References

Additional resources about the objective.

  1. CDC. Hepatitis Surveillance Report (56). 1995.
  2. Centers for Disease Control and Prevention (CDC). Case definitions for infectious conditions under public health surveillance. Morbidity and Mortality Weekly Report 46 (RR-10), 1997. (Updated case definitions can be found at: http://www.cdc.gov/ncphi/disss/nndss/casedef/introduction.htm).
  3. Margolis, H.S.; Alter, M.J.; Hadler, S.C. Hepatitis B: Evolving epidemiology and implications for control. Seminars in Liver Disease 11(2): 84-92, 199
IID-25 Reduce hepatitis B

About the Data

Description of the data source, numerator, denominator, survey questions, and other relevant details about the national estimate.

National Data Source
National Notifiable Diseases Surveillance System (NNDSS); Centers for Disease Control and Prevention, Public Health Surveillance and Informatics Program Office (CDC/PHSIPO)
Changed Since the Healthy People 2020 Launch
No
Measure
per 100,000 
Baseline (Year)
2.0 (2007)
Target
1.5
Target-Setting Method
Maintain consistency with national programs, regulations, policies, and laws.
Numerator
Number of symptomatic hepatitis B cases among persons aged 19 years or older reported in the past 12 months
Denominator
Total population of persons aged 19 years and older in reporting states
Data Collection Frequency
Annual
Comparable Healthy People 2010 Objective
Adapted from HP2010 objective
Methodology Notes

A case definition for new symptomatic cases of hepatitis B is available from CDC.

References

Additional resources about the objective.

  1. CDC. Vaccination coverage among adolescents 13—17 years--- United States, 2007. MMWR 2008;57(40); 1100-1103
  2. Centers for Disease Control and Prevention (CDC). Case definitions for infectious conditions under public health surveillance. http://wwwn.cdc.gov/nndss/beta/bcasedefDefault.aspx
  3. Daniels D, Grytdal S, Wasley A. Surveillance for acute viral hepatitis - United States, 2007. MMWR Surveillance Summary. May 22 2009;58(3):1-27. http://www.cdc.gov/mmwr/PDF/ss/ss5803.pdf

About the Data

Description of the data source, numerator, denominator, survey questions, and other relevant details about the national estimate.

National Data Source
National Notifiable Diseases Surveillance System (NNDSS); Centers for Disease Control and Prevention, Public Health Surveillance and Informatics Program Office (CDC/PHSIPO)
Changed Since the Healthy People 2020 Launch
No
Measure
number 
Baseline (Year)
285 (2007)
Target
215
Target-Setting Method
Maintain consistency with national programs, regulations, policies, and laws.
Numerator
Number of reported symptomatic hepatitis B cases among those who had a valid response (yes or no) to the question about injection drug use on CDC Viral Hepatitis Case Record for Reporting of Patients With Symptomatic Acute Viral Hepatitis, Form 53 1
Data Collection Frequency
Annual
Comparable Healthy People 2010 Objective
Adapted from HP2010 objective
Methodology Notes

A case definition for new symptomatic cases of hepatitis B is available from CDC.

References

Additional resources about the objective.

  1. CDC. Vaccination coverage among adolescents 13—17 years--- United States, 2007. MMWR 2008;57(40); 1100-1103
  2. Centers for Disease Control and Prevention (CDC). Case definitions for infectious conditions under public health surveillance. http://wwwn.cdc.gov/nndss/beta/bcasedefDefault.aspx
  3. Daniels D, Grytdal S, Wasley A. Surveillance for acute viral hepatitis - United States, 2007. MMWR Surveillance Summary. May 22 2009;58(3):1-27. http://www.cdc.gov/mmwr/PDF/ss/ss5803.pdf

About the Data

Description of the data source, numerator, denominator, survey questions, and other relevant details about the national estimate.

National Data Source
National Notifiable Diseases Surveillance System (NNDSS); Centers for Disease Control and Prevention, Public Health Surveillance and Informatics Program Office (CDC/PHSIPO)
Changed Since the Healthy People 2020 Launch
No
Measure
number 
Baseline (Year)
62 (2007)
Target
45
Target-Setting Method
Maintain consistency with national programs, regulations, policies, and laws.
Numerator
Number of reported (in the past 12 months) symptomatic hepatitis B cases among males that indicated homosexual or bisexual preference
Data Collection Frequency
Annual
Comparable Healthy People 2010 Objective
Adapted from HP2010 objective
Methodology Notes

A case definition for new symptomatic cases of hepatitis B is available from CDC.

References

Additional resources about the objective.

  1. CDC. Vaccination coverage among adolescents 13—17 years--- United States, 2007. MMWR 2008;57(40); 1100-1103
  2. Centers for Disease Control and Prevention (CDC). Case definitions for infectious conditions under public health surveillance. http://wwwn.cdc.gov/nndss/beta/bcasedefDefault.aspx
  3. Daniels D, Grytdal S, Wasley A. Surveillance for acute viral hepatitis - United States, 2007. MMWR Surveillance Summary. May 22 2009;58(3):1-27. http://www.cdc.gov/mmwr/PDF/ss/ss5803.pdf

About the Data

Description of the data source, numerator, denominator, survey questions, and other relevant details about the national estimate.

National Data Source
National Notifiable Diseases Surveillance System (NNDSS); Centers for Disease Control and Prevention, Public Health Surveillance and Informatics Program Office (CDC/PHSIPO)
Changed Since the Healthy People 2020 Launch
No
Measure
per 100,000 
Baseline (Year)
0.28 (2007)
Target
0.25
Target-Setting Method
Maintain consistency with national programs, regulations, policies, and laws.
Numerator
Number of new symptomatic hepatitis C cases reported in the past 12 months
Denominator
Total population in reporting states
Data Collection Frequency
Annual
Comparable Healthy People 2010 Objective
Adapted from HP2010 objective
Methodology Notes

A case definition for new symptomatic cases of hepatitis C is available from CDC.

References

Additional resources about the objective.

  1. Centers for Disease Control and Prevention (CDC). Case definitions for infectious conditions under public health surveillance. http://www.cdc.gov/osels/ph_surveillance/nndss/casedef/hepatitisacurrent.htm
  2. Daniels D, Grytdal S, Wasley A. Surveillance for acute viral hepatitis - United States, 2007. MMWR Surveillance Summary. May 22 2009;58(3):1-27. http://www.cdc.gov/mmwr/PDF/ss/ss5803.pdf

About the Data

Description of the data source, numerator, denominator, survey questions, and other relevant details about the national estimate.

National Data Source
National Health and Nutrition Examination Survey (NHANES); Centers for Disease Control and Prevention, National Center for Health Statistics (CDC/NCHS)
Changed Since the Healthy People 2020 Launch
No
Measure
percent 
Baseline (Year)
49.0 (2002-2007)
Target
60.0
Target-Setting Method
Projection/trend analysis
Numerator
Number of respondents to the NHANES who indicate they were aware they had hepatitis C prior to the NHANES laboratory testing
Denominator
Number of respondents to NHANES who tested positive for chronic hepatitis C based on NHANES laboratory testing
Data Collection Frequency
Annual
Comparable Healthy People 2010 Objective
Not applicable
Methodology Notes

Due to the small sample size, pooling data over multiple years is necessary to produce stable estimates.

References

Additional resources about the objective.

  1. Volk M, Tocco R, Saini S, Lok A. Public health impact of antiviral therapy for hepatitis C in the United States. Hepatology. 2009;50:1750-55.

About the Data

Description of the data source, numerator, denominator, survey questions, and other relevant details about the national estimate.

National Data Source
REACH (Racial and Ethnic Approaches to Community Health) Risk Factor Survey; Centers for Disease Control and Prevention (CDC)
Changed Since the Healthy People 2020 Launch
No
Measure
*** Missing *** 
Numerator
*** Missing ***
Comparable Healthy People 2010 Objective
Not applicable

References

Additional resources about the objective.

  1. Weinbaum C, Williams I, Wong S. CDC Recommendations for Identification and Public Health Management of Persons with Chronic Hepatitis B Virus Infection. MMWR September 19, 2008; 57(No. RR-08):1-20. http://www.cdc.gov/mmwr/preview/mmwrhtml/rr5708a1.htm

About the Data

Description of the data source, numerator, denominator, survey questions, and other relevant details about the national estimate.

National Data Source
National TB Surveillance System (NTBSS); Centers for Disease Control and Prevention, National Center for HIV/AIDS, Viral Hepatitis, STD, and TB Prevention (CDC/NCHHSTP)
Changed Since the Healthy People 2020 Launch
Yes
Measure
per 100,000 
Baseline (Year)
4.8 (2005)
Target
1.0
Target-Setting Method
Maintain consistency with national programs, regulations, policies, and laws.
Numerator
Number of confirmed new cases of tuberculosis reported to CDC by local health departments in all 50 States and the District of Columbia
Denominator
Number of persons
Data Collection Frequency
Annual
Comparable Healthy People 2010 Objective
Retained from HP2010 objective
Methodology Notes

A confirmed case definition for tuberculosis is available from CDC.

Revision History

Any change to the objective text, baseline, target, target-setting method or data source since the Healthy People 2020 launch.

Description of Changes Since the Healthy People 2020 Launch

The baseline was revised from 4.9 (2005) to 4.8 (2005) when the denominator was revised from Postcensal Estimates to Intercensal Estimates of the Resident Population.

References

Additional resources about the objective.

  1. Centers for Disease Control and Prevention (CDC). Case definitions for infectious conditions under public health surveillance. Morbidity and Mortality Weekly Report 46 (RR-10), 1997. (Updated case definitions can be found at: http://www.cdc.gov/ncphi/disss/nndss/casedef/introduction.htm).

About the Data

Description of the data source, numerator, denominator, survey questions, and other relevant details about the national estimate.

National Data Source
National TB Surveillance System (NTBSS); Centers for Disease Control and Prevention, National Center for HIV/AIDS, Viral Hepatitis, STD, and TB Prevention (CDC/NCHHSTP)
Changed Since the Healthy People 2020 Launch
Yes
Measure
percent 
Baseline (Year)
81.9 (2005)
Target
93.0
Target-Setting Method
Maintain consistency with national programs, regulations, policies, and laws.
Numerator
Number of persons with confirmed new cases of tuberculosis who were alive at diagnosis, with an initial drug regimen of one or more drugs prescribed, who did not die during therapy, and who completed curative therapy within 12 months of diagnosis
Denominator
Number of persons with confirmed new cases of tuberculosis who were alive at diagnosis, with an initial drug regimen of one or more drugs prescribed, and who did not die during therapy
Data Collection Frequency
Annual
Comparable Healthy People 2010 Objective
Retained from HP2010 objective
Methodology Notes

A confirmed case definition for tuberculosis is available from CDC.

Revision History

Any change to the objective text, baseline, target, target-setting method or data source since the Healthy People 2020 launch.

Description of Changes Since the Healthy People 2020 Launch

The baseline was revised from 83.8 (2006) to 82.8 (2005) to make the baseline year and data consistent with IID-29 estimates. In addition, the revision incorporates new data that were not available at the HP2020 launch. The target was not revised.

References

Additional resources about the objective.

  1. Centers for Disease Control and Prevention (CDC). Case definitions for infectious conditions under public health surveillance. Morbidity and Mortality Weekly Report 46 (RR-10), 1997. (Updated case definitions can be found at: http://www.cdc.gov/ncphi/disss/nndss/casedef/introduction.htm).

About the Data

Description of the data source, numerator, denominator, survey questions, and other relevant details about the national estimate.

National Data Source
Aggregate Reports for Tuberculosis Program Evaluation; Centers for Disease Control and Prevention, National Center for HIV/AIDS, Viral Hepatitis, STD, and TB Prevention (CDC/NCHHSTP)
National TB Surveillance System (NTBSS)
Changed Since the Healthy People 2020 Launch
Yes
Measure
percent 
Baseline (Year)
68.1 (2007)
Target
79.0
Target-Setting Method
Maintain consistency with national programs, regulations, policies, and laws.
Numerator
Number of persons completing treatment for latent tuberculosis infection (LTBI) who, during the contact investigations of AFB sputum-smear positive TB cases,  have been found to have LTBI and initiated treatment
Denominator
Number of persons who, during the contact investigations of AFB sputum-smear positive TB cases,  have been found to have LTBI and initiated treatment
Data Collection Frequency
Annual
Comparable Healthy People 2010 Objective
Retained from HP2010 objective
Methodology Notes

Treatment for latent TB infection substantially reduces the risk that TB infection will progress to disease. Certain groups are at very high risk of developing TB disease if infected. Identifiable population groups at high risk for TB vary in time and geographic area, depending on unique and changing TB related demographics.

Revision History

Any change to the objective text, baseline, target, target-setting method or data source since the Healthy People 2020 launch.

Description of Changes Since the Healthy People 2020 Launch

The baseline estimate was revised from 64.3% (2007) to 68.1% (2007). The former estimate was submitted as preliminary data. The latter estimate reflects the final national estimate. The target was not revised. Added "and initiated treatment" to the numerator and denominator for clarity because not everyone with LTBI actually start treatment. Added phrases to the objective statement for clarity: Increase the percentage of *contacts to sputum smear-positive *tuberculosis* cases who complete treatment after being diagnosed with latent tuberculosis infection *(LTBI) and initiated treatment for LTBI.*

References

Additional resources about the objective.

  1. Aggregate Reports for Tuberculosis Program Evaluation (ARPEs): Training Manual and Users Guide at http://www.cdc.gov/tb/pubs/PDF/ARPEs%20Manual.pdf.

About the Data

Description of the data source, numerator, denominator, survey questions, and other relevant details about the national estimate.

National Data Source
National TB Surveillance System (NTBSS); Centers for Disease Control and Prevention, National Center for HIV/AIDS, Viral Hepatitis, STD, and TB Prevention (CDC/NCHHSTP)
Changed Since the Healthy People 2020 Launch
Yes
Measure
percent 
Baseline (Year)
32.0 (2008)
Target
77.0
Target-Setting Method
Maintain consistency with national programs, regulations, policies, and laws.
Numerator
Number of patients with a positive NAAT result within 2 days of specimen collection
Denominator
Number of all the culture confirmed cases of tuberculosis
Comparable Healthy People 2010 Objective
Adapted from HP2010 objective
Methodology Notes

Nucleic acid amplification tests are capable of detecting Mycobacterium tuberculosis in a specimen within 48 hours of collection. Concerns regarding sensitivity, cost, quality control, availability and special expertise requirements have hindered widespread use of such tests. Upgrading TB laboratory capabilities and facilities, improving training in state-of-the-art mycobacteriology, and evaluating proficiency should better enable laboratories to apply these rapid tests to the diagnosis of TB.

Revision History

Any change to the objective text, baseline, target, target-setting method or data source since the Healthy People 2020 launch.

Description of Changes Since the Healthy People 2020 Launch

The objective statement was revised from "Reduce the average time for laboratories to confirm and report tuberculosis cases" to "Increase the proportion of culture confirmed TB patients with a positive nucleic acid amplification test (NAAT) result reported within 2 days of specimen collection" in order to make the objective statement consistent with the desired direction and value label.

References

Additional resources about the objective.

  1. Starks, A.M., T.L. Dalton, F. Tyrrell, B. Metchock. “Use of Nucleic Acid Amplification Tests (NAAT) by U.S. Public Health Laboratories (PHL) for detection of Mycobacterium tuberculosis complex in Clinical Specimens”. Poster presented as part of the North American Region of the International Union Against TB and Lung Disease, Orlando, Florida, 11-13 March 2010.
  2. Updated Guidelines for the Use of Nucleic Acid Amplification Tests in the Diagnosis of Tuberculosis. MMWR. January 16, 2009 / 58(01); 7-10.

About the Data

Description of the data source, numerator, denominator, survey questions, and other relevant details about the national estimate.

National Data Source
National TB Surveillance System (NTBSS); Centers for Disease Control and Prevention, National Center for HIV/AIDS, Viral Hepatitis, STD, and TB Prevention (CDC/NCHHSTP)
Changed Since the Healthy People 2020 Launch
Yes
Measure
percent 
Baseline (Year)
73.3 (2008)
Target
80.6
Target-Setting Method
10 percent improvement
Numerator
Number of reported TB cases among persons aged 25 to 44 years with a negative, positive or indeterminate HIV test result
Denominator
Number of reported TB cases (based on TB case report forms) among persons aged 25 to 44 years
Comparable Healthy People 2010 Objective
Retained from HP2010 objective
Methodology Notes

The data are based on the CDC report of verified case of Tuberculosis, Form 72.9A, Rev. 5/93.

Revision History

Any change to the objective text, baseline, target, target-setting method or data source since the Healthy People 2020 launch.

Description of Changes Since the Healthy People 2020 Launch

The original baseline was revised from 65.0 to 73.3. The target was adjusted from 71.5 to 80.6 to reflect the revised baseline using the original target-setting method. This objective was moved from the HP2020 HIV topic area to the Immunization and Infectious Diseases topic area.